Inhibition of Nuclear DNA Sensing by Herpes Simplex Virus 1 by Orzalli, Megan Jenkins
 Inhibition of Nuclear DNA Sensing by Herpes Simplex Virus 1
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Orzalli, Megan Jenkins.  2013.  Inhibition of Nuclear DNA Sensingby Herpes Simplex Virus 1.  Doctoral dissertation, Harvard
University.
Accessed April 17, 2018 4:09:23 PM EDT
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:11156815
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! 2013 Megan Horn Orzalli 
All rights reserved 
! """!
Dissertation Advisor: Dr. David Knipe    Megan Horn Orzalli 
 
 
Inhibition of Nuclear DNA Sensing by Herpes Simplex Virus 1 
 
 
Abstract 
 
The detection of immunostimulatory DNA is well documented to occur at 
several cellular sites, but there is limited evidence of nuclear innate DNA sensing.  
Prior to this study, the detection of herpesviral DNA was thought to be restricted 
to the cytosol so as to limit the sensing of host DNA in the nucleus.  However, 
given the nuclear lifecycle of these viruses, we hypothesized that viral DNA could 
be sensed in the nucleus of infected cells. To test this hypothesis we examined 
the activation of interferon regulatory factor 3 (IRF-3) in response to herpes 
simplex virus 1 (HSV-1) infection of primary human foreskin fibroblasts (HFF).  
Using a mutant defective for expression of all viral genes, we observed that the 
release of viral DNA into the nucleus is necessary to activate IRF-3 signaling.  
Furthermore, we determined this response to be dependent on nuclear-localized 
interferon inducible protein 16 (IFI16) and the cytoplasmic stimulator of interferon 
genes (STING) adaptor protein. 
The HSV-1 ICP0 E3 ubiquitin ligase has been observed to inhibit the 
induction of IRF-3 responsive genes in human fibroblasts;  therefore, we 
investigated the effects of ICP0 on this pathway.  We observed that nuclear ICP0 
inhibits the induction of type I interferon by sequestering IRF-3 away from cellular 
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promoters and by promoting the degradation of IFI16 in a proteasome and RING-
finger dependent manner. 
IFI16 also plays a role in the restriction of HSV-1 replication by a STING-
independent mechanism.  We observed an IFI16-dependent reduction in 
immediate-early gene expression of ICP0-null mutant viruses in human 
fibroblasts. This response was not limited to viral DNA as the expression of 
transfected DNA was also inhibited by IFI16.  Depletion of IFI16 did not affect the 
recruitment of PML to viral genomes, indicating this response does not involve 
the intrinsic resistance activity of ND10 domains.   
Together, these studies show that nuclear IFI16 in normal human cells 
serves as both a sensor of viral DNA to initiate an innate signaling pathway and 
to activate an intrinsic resistance mechanism to foreign DNA.  Furthermore we 
document a mechanism by which HSV-1 inhibits both these pathways through 
the expression of ICP0. 
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1.1 The Herpesviridae Family 
 
The Herpesviridae family is comprised of a large number of double-stranded 
DNA viruses that were initially defined by structural similarities within the virion 
(Roizman et al., 2013).  The linear genome of these viruses is contained within an 
icosahedral capsid, which is surrounded by an amorphous proteinaceous layer known 
as the tegument, and an envelope that contains viral glycoproteins.  Along with the 
noted structural similarities, several biological activities are also shared amongst 
members of this virus family;  including the expression of a number of enzymatic 
proteins involved in the virus lifecycle, the nuclear replication of the viral genome, the 
destruction of the host cell upon productive infection, and the ability of these viruses to 
establish latency in their natural host. 
Within Herpesviridae, individual viruses are classified into three subfamilies 
(Alphaherpesvirinae, Betaherpesvirinae, and Gammaherpesvirinae) based on shared 
biological characteristics.  Members of the Alphaherpesvirinae subfamily have a broad 
host range, replicate quickly, and establish latency in sensory ganglia of infected hosts. 
Within this subfamily, herpes simplex virus 1 and 2 (HSV-1, HSV-2) cause recurring oral 
and genital lesions, while varicella zoster virus is the causative agent of chicken pox and 
shingles.    
In contrast to the alpha-herpesviruses, members of the Betaherpesvirinae 
subfamily are more restricted in their host range and replicate more slowly in cell 
culture.  Furthermore, these viruses establish latency in cells of myeloid lineage.   
Infection with betaherpesviruses is often asymptomatic;  however, these viruses can 
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cause severe disease in congenitally infected infants and immunocompromised 
individuals, including transplant recipients and individuals infected with human 
immunodeficiency virus (HIV).  Human cytomegalovirus (HCMV), a major member of 
this subfamily, can cause hearing loss in symptomatic infants and is a major factor in 
post-transplant pathology.  
  The gammaherpesviruses are the most restrictive in their cellular tropism and 
mainly replicate in lymphoid cells.  Unlike the alpha- and beta-herpesviruses, which 
undergo robust lytic replication in vitro, gammaherpesviruses generally default to 
latency in cell culture systems.  For this reason, the latent lifecycle of 
gammaherpesviruses has been more thoroughly investigated than other Herpesviridae 
family members (Speck and Ganem, 2010).  This family includes several significant 
human pathogens, including Epstein Barr virus (EBV), which is the causative agent of 
infectious mononucleosis.  
 
1.2 HSV Epidemiology 
 In the United States approximately 57.7% and 17% of adults are seropositive for 
HSV-1 and HSV-2, respectively (Xu et al., 2006).  A majority of HSV-1 seropositive 
individuals become infected before the age of 5, while the incidence of HSV-2 infection 
increases following the commencement of sexual activity.  Both viruses can result in the 
formation of characteristic herpetic lesions at oral or genital mucosal surfaces.  These 
lesions normally clear in the absence of intervention;  however, in rare cases, HSV can 
cause severe morbidity and mortality in infected individuals.  For instance, HSV infection 
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of the cornea, either during primary infection or upon reactivation of latent virus, can 
result in blindness due to the induction of a localized inflammatory response.   Both 
HSV-1 and HSV-2 infection can result in herpes simplex encephalitis (HSE), where virus 
replication occurs in the brain, causing severe damage to the temporal lobe and, when 
untreated, a high incidence of death.  In addition to being the causative agents in the 
diseases described above, evidence has emerged suggesting that HSV-2 infection 
increases the risk of human immunodeficiency virus (HIV) acquisition by 2- to 3-fold 
(Wald and Link, 2002).  While the relationship between HSV-2 and HIV is not fully 
understood, disruption of the mucosal barrier during herpesvirus infection may recruit 
immune cells, increasing the localized pool of HIV-targeted cells.   
 
1.3 HSV Pathogenesis 
Herpes simplex viruses undergo a complicated biphasic lifecycle, which includes 
both lytic and latent stages.  During an initial infection, the virus infects mucosal 
epithelium and undergoes a robust program of replication and production of progeny 
virions.  Following virus release from infected epithelial cells, latency is established in 
enervating sensory ganglia.  Under certain conditions the latent virus can reactivate, 
express lytic gene products and produce progeny virus.  This reactivation event may be 
asymptomatic or replication competent virus may travel to the axonal termini inducing a 
secondary round of lytic replication at mucosal surfaces. 
 
1.3.1 Viral Entry 
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HSV entry is mediated by a fusion event between the viral envelope and a host 
cell membrane.  Initially, the virus attaches to target cells via interactions between the 
virion glycoproteins gB and/or gC and heparan sulfate, a glycosaminoglycan 
ubiquitously expressed on cell surfaces.  This brings the viral gD glycoprotein in close 
proximity to its cognate cellular receptors, which triggers entry by the virion fusion 
machinery, gB and gH/gL.  A variety of cellular proteins have been identified as 
receptors for gD binding, including herpesvirus entry mediator (HVEM) and nectin-1 
[reviewed in (Spear, 2004)]. 
 HSV can utilize two distinct entry pathways in a cell-type dependent manner.  
Initial studies in Vero and Hep2 cells suggested that HSV entry occurs by a pH-
independent direct fusion event at the plasma membrane (Wittels and Spear, 1991).  
However, studies in additional cell lines, including HeLa and nectin-1 expressing CHO-
cells, have identified an additional entry pathway utilizing endocytosis (Nicola et al., 
2003).  The molecular mechanisms that govern the entry pathway used have not been 
defined;  however, differences in gD/receptor binding have been proposed (Karasneh 
and Shukla, 2011).  In either case, both entry pathways can result in productive virus 
infection. 
Following fusion with a cellular membrane, viral capsids are released into the 
cytoplasm and transported along microtubules to the nucleus where they accumulate at 
nuclear pore complexes (NPC) in an importin !-dependent manner (Ojala et al., 2000).  
Viral DNA is then rapidly injected into the nucleus, leaving empty viral capsids at the 
nuclear periphery.  The viral tegument has been implicated in mediating the interaction 
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with NPC, because purified capsids lacking tegument are unable to bind to isolated 
nuclei in vitro (Ojala et al., 2000).  While the exact viral proteins that mediate this 
interaction are unknown, inhibition of tegument VP1-2 cleavage, either through the use 
of the tsB7 temperature sensitive mutant (Batterson et al., 1983) or by chemical 
intervention (Jovasevic et al., 2008), causes the accumulation of electron dense capsids 
at the nuclear periphery, implicating this protein in the release of viral DNA.  
 
1.3.2 Viral Gene Expression 
 Following the release of the linear viral genome into the nucleus, the DNA 
circularizes (Garber et al., 1993) and is rapidly chromatinized by host cell machinery 
(Cliffe and Knipe, 2008; Oh and Fraser, 2008).  During lytic infection, histone 
association with HSV DNA is looser than the cellular chromatin (Lacasse and Schang, 
2010) and is also less densely packed (Cliffe and Knipe, 2008).  However, in the 
absence of viral gene expression HSV DNA is associated with increased levels of 
histone H3 as well as heterochromatic marks that are known to promote higher order 
chromatin structures indicative of transcriptional repression (Ferenczy and DeLuca, 
2009).  HSV proteins have been implicated in preventing this repression by modulating 
the chromatin structure during the early stages of infection (Knipe and Cliffe, 2008).   
Lytic infection is characterized by a tightly regulated cascade of viral gene 
expression (Honess and Roizman, 1974) that is generally categorized into three 
classes: immediate-early, early, and late genes.  The immediate-early genes are 
expressed in the absence of de novo viral protein synthesis, but expression is greatly 
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enhanced by the presence of the tegument-associated VP16 transactivator protein (Ace 
et al., 1989).  The viral VP16 protein, in concert with the cellular proteins HCF-1 and 
Oct-1, binds to TATGARAT containing cis-regulatory elements in HSV immediate-early 
promoters to induce the expression of ICP0, -4, -22, -27, and -47 [reviewed in (Roizman 
et al., 2013)].  Members of the immediate-early class of proteins are involved in 
promoting the expression of the early-genes, which encode a range of proteins involved 
in viral DNA replication and nucleotide metabolism.  The late genes are expressed upon 
viral DNA replication and consist of structural proteins and those involved in viral 
egress. 
 
1.3.3 Viral Egress 
Encapsidation of viral DNA leads to the formation of mature nucleocapsids, which 
must cross the nuclear membrane and transit through the cytoplasm in order to bud at 
the Golgi membranes.  This process involves multiple envelopment and de-
envelopment events as the capsid transits through the cell [reviewed in (Johnson and 
Baines, 2011)].  The first step in HSV nuclear egress involves the primary envelopment 
of nucleocapsids at the intranuclear membrane (INM).  To gain access to the INM, viral 
proteins that make up the nuclear envelopment complex, including UL31 and UL34, 
mediate an extensive restructuring of the nuclear lamina (Reynolds et al., 2004), an 
underlying meshwork of cellular proteins that provide structure to the nuclear 
membrane.  Enveloped virus particles in the inner nuclear space fuse with the outer 
nuclear membrane to release de-enveloped viral capsids into the cytoplasm.  Here, the 
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capsids become associated with a majority of the tegument proteins found within 
extracellular virions.  These tegument-coated viral capsids undergo a second round of 
envelopment when they bud into cytoplasmic organelles like the trans-Golgi network.  
The enveloped virus is then transported to the plasma membrane through the cellular 
exocytosis pathway and secreted into the extracellular space. 
 
1.3.4 HSV Latent Infection 
In contrast to the lytic cycle of HSV replication, far less is known about how 
herpes simplex viruses establish, maintain, and reactivate from latency.  Following 
spread from the primary site of infection, HSV infects sensory neurons of the trigeminal 
or dorsal root ganglia.  Retrograde transport of the viral nucleocapsid along axons leads 
to the deposition of the viral genome in cell bodies, where it is maintained as a circular 
episome in the nucleus.  Unlike lytic HSV genomes, latent HSV DNA is associated with 
a regular array of nucleosomes and forms a classical laddering pattern following 
digestion with micrococcal nuclease (Deshmane and Fraser, 1989). 
Latent infection is associated with a repression of viral gene expression, except 
for the latency-associated transcript (LAT), which can be detected at high levels in 
infected neurons.  While LAT expression is not essential for the establishment of 
latency, it does negatively regulate lytic gene expression during this process (Chen et 
al., 1997; Garber et al., 1997).  Furthermore, LAT -/- viruses have reduced levels of the 
H3K27me3 facultative heterochromatic modification on histones associated with HSV 
lytic gene promoters (Cliffe et al., 2009; Wang et al., 2005).  Together, these results 
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indicate that LAT expression has a role in the repression of the viral genome during 
latency, although the exact mechanism(s) by which LAT acts remains elusive.    
Periodic reactivation of latent HSV genomes occurs upon local injury, 
immunosuppression, or exposure to stimuli, such as ultra-violet (UV) light, hyperthermia, 
or emotional stress.  Changes in chromatin structure are associated with reactivation 
(Neumann et al., 2007) and lytic gene expression is de-repressed resulting in the 
production of progeny virions, which travel in an anterograde fashion to the primary site 
of infection. 
 
1.4 Infected Cell Protein 0 
Infected cell protein 0 (ICP0) is encoded by the !0 gene, which maps to the 
inverted repeats of the unique long (uL) component of the HSV genome;  therefore, the 
virus contains two copies of the gene.   It is one of the few viral gene products to require 
splicing during HSV infection, and the unspliced mRNA consists of three exons 
separated by two introns.  The 2.7 kb spliced ICP0 mRNA encodes a 775 amino acid 
protein with a molecular weight of approximately 110 kDa. 
ICP0 contains a nuclear localization signal in exon three and accumulates in the 
nucleus at early time points post-infection (Mullen et al., 1994).  At late stages of 
infection, ICP0 translocates to the cytoplasm following viral DNA synthesis and/or late 
gene expression (Kawaguchi et al., 1997; Lopez et al., 2001).  ICP0 has been reported 
to be a component of the viral tegument (Yao and Courtney, 1992) and has been 
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implicated in efficient trafficking of the viral capsids to the host nuclear periphery 
(Delboy and Nicola, 2011). 
 
1.4.1 The E3 Ubiquitin Ligase Activity of ICP0 
ICP0 contains a C3HC4 RING (really interesting new gene) finger domain, which 
exhibits E3 ubiquitin ligase activity in vitro and in vivo.  Recombinant HSV-1 viruses with 
mutations in the RING finger domain of ICP0 functionally resemble ICP0-null viruses, 
indicating this domain is important for ICP0 function during infection (Everett, 1989; 
Lium and Silverstein, 1997).  ICP0 has been shown to promote the degradation of a 
variety of cellular proteins [reviewed in (Boutell and Everett, 2012)], including USP7 
(Canning et al., 2004), PML (Chelbi-Alix and de The, 1999), and RNF8 (Lilley et al., 
2010).  The diversity of these target proteins has indicated that ICP0 employs multiple 
mechanisms for substrate targeting.   
One mechanism of ICP0-dependent substrate targeting occurs through a direct 
protein-protein interaction with the target protein.  This is the case for the degradation of 
USP7, which is mediated by the C-terminus of ICP0.  Mutation of one amino acid (K620) 
is sufficient to abolish the interaction with USP7 (Everett et al., 1999).  Binding to USP7 
enhances ICP0 stability by inhibiting autoubiquitination of the protein (Boutell et al., 
2005). 
Recently, ICP0 was shown to mimic a cellular fork-head associated (FHA) 
binding site through the phosphorylation of a conserved threonine (amino acid residue 
67) within the N-terminus of the protein (Chaurushiya et al., 2012).  This protein 
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modification allows ICP0 to interact with and target the RNF8 cellular E3 ubiquitin ligase 
for degradation during infection.  Several cellular proteins, particularly those implicated 
in the DNA damage response contain FHA domains;   however, while ICP0 can interact 
with additional members of this family (CKH2 and Nbs1), it does not appear to promote 
the degradation of these recently described interactors (Chaurushiya et al., 2012). 
ICP0 has also been shown to promote the widespread loss of SUMO-conjugated 
proteins, including specific PML isoforms. This occurs in a SUMO-dependent manner, 
which has resulted in ICP0 being categorized as a SUMO-targeted ubiquitin ligase 
(STUbl).  Several putative SUMO interaction motifs (SIMs) have been identified within 
the ICP0 sequence, and disruption of these sequences through mutational alteration 
inhibits the ability of transfected ICP0 to complement an ICP0-null virus (Boutell et al., 
2011).  At least one additional mechanism of ICP0-substrate targeting exists as ICP0 
has been shown to promote the degradation of the PML isoform I independently of the 
mechanisms discussed above (Cuchet-Lourenco et al., 2012). 
 
1.4.2 Effects on Gene Expression 
ICP0 is one of the first proteins to be expressed during lytic infection.  While not 
essential for virus replication, viral mutants that are defective for ICP0 are severely 
attenuated for growth, particularly at low multiplicity of infection (MOI). The defect in 
ICP0-null virus replication is cell-type dependent with the greatest defect observed in 
human fibroblasts (~1000 fold) and Vero cells (~100 fold).  ICP0 mutant virus growth 
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can be complemented by the osteosarcoma U2OS cell line, which most likely lacks a 
component involved in the repression of HSV-1 genomes (Hancock et al., 2006). 
ICP0 transactivates viral gene expression but does not mediate this effect by 
binding to viral DNA.  Instead, ICP0 has been proposed to regulate viral chromatin 
structure in such a way as to enhance viral transcription.  Consistent with this 
hypothesis, the expression of ICP0 promotes both histone removal and acetylation of 
viral DNA during lytic infection and the establishment of quiescence (Cliffe and Knipe, 
2008; Ferenczy and DeLuca, 2009).  Furthermore, the addition of ICP0 in trans results 
in a decrease in heterochromatin on quiescent genomes and a subsequent increase in 
viral promoter activity (Ferenczy and DeLuca, 2011). 
The mechanism(s) by which ICP0 promotes these changes in chromatin 
structure have not been defined, though several possible mechanisms have been 
proposed.  Nuclear domain 10 (ND10) associated proteins have been implicated in viral 
silencing (Boutell and Everett, 2012), and ICP0 disrupts ND10 accumulation at sites 
adjacent to viral DNA.  However, disruption of ND10 by the simultaneous knockdown of 
PML, Sp100 and hDaxx only partially rescues the replication of ICP0-null viruses in 
human fibroblasts (Glass and Everett, 2012), indicating additional silencing mechanisms 
exist.  Furthermore, a direct link between ND10 components and the observed 
chromatin effects on viral DNA have not been made.   
 
1.5 The Innate Immune Response to Viral Infection 
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In an influential paper published in 1989, Charles Janeway hypothesized that 
activation of adaptive immunity is controlled by an initial innate response to a microbial 
infection (Janeway, 1989).  He proposed that the host encodes pattern recognition 
receptors (PRRs), which recognize conserved pathogen associated molecular patterns 
(PAMPs) that are present or produced during bacterial or viral infection.  Since the 
publication of this theory a large number of germline-encoded receptors have been 
identified, which recognize a wide variety of PAMPs.  These receptors are classified 
according to their ligand specificity, localization, and evolutionary similarity, and include 
the Toll-like receptors (TLRs), the nucleotide binding and oligomerization domain-like 
receptors (NLRs), the RIG-I like receptors (RLRs), the AIM2-like receptors (ALRs), and 
a variety of cytosolic DNA sensors.  
Upon sensing their cognate ligands these sensors trigger signaling cascades that 
induce the expression of antimicrobial factors, including pro-inflammatory cytokines and 
type I interferons (IFN" and IFN!).  The induction of pro-inflammatory cytokines 
generally relies on the activation of the nuclear factor #B (NF-#B) transcription factor, 
while expression of IFN" and IFN! are induced by activation of NF-#B, interferon 
regulatory factors (IRFs), and additional transcription factors.  Secreted pro-
inflammatory cytokines and chemokines act upon resident myeloid cells (macrophage 
and dendritic cells), leading to their activation and migration to secondary lymphoid 
tissues where they present foreign peptide to T-cells.  In contrast, secretion of type I 
interferons mediates a more localized response by acting directly on infected cells 
through the ubiquitously expressed type I interferon receptor (IFNAR).  Signaling 
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through IFNAR activates the JAK-STAT signaling pathway [reviewed in (Stark and 
Darnell, 2012)] and induces the transcription of interferon-stimulated genes (ISGs) 
whose protein products mediate the antiviral state.  It has since been shown that a 
subset of ISGs can be expressed independently of IFN, but signaling through this 
pathway enhances their expression substantially (Wathelet et al., 1992). 
Interferon regulatory factor 3 (IRF-3) is a critical component of the innate immune 
response to virus infection and bridges the initial sensing of viral PAMPs to the 
production of type I IFNs and ISGs [reviewed in (Hiscott, 2007)].  This constitutively 
expressed transcription factor is localized exclusively in the cytoplasm in the absence of 
stimuli.  However, signaling through PRRs leads to the activation of the serine-threonine 
kinases TANK binding kinase I (TBK1) and IKKε.  These kinases have been shown to 
phosphorylate Ser/Thr residues in the C-terminus of IRF-3, leading to its 
homodimerization and nuclear translocation (Fitzgerald et al., 2003).  Activated nuclear 
IRF-3 interacts with the co-activators CBP/p300 and undergoes a conformational 
change, which allows binding to interferon stimulated response elements (ISRE) in the 
promoter regions of ISGs (Lin et al., 1998; Wathelet et al., 1998; Weaver et al., 1998; 
Yoneyama et al., 1998).  CBP/p300 promotes transcription of a variety of cellular genes 
through acetylation of histones, the relaxation of chromatin structure, and the 
recruitment of RNA polymerase II (Martinez-Balbas et al., 1998).  Following 
transcriptional activation, IRF-3 is degraded by the ubiquitin proteasome pathway to 
down-regulate type I IFN production (Bibeau-Poirier et al., 2006; Lin et al., 1998). 
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1.5.1 Innate Sensors of HSV Infection 
HSV infection activates innate signaling pathways by cellular recognition of three 
viral PAMPs:  protein, RNA, or DNA.  Within the membrane-bound TLR family, three of 
the eleven known members recognize HSV at different stages of infection.  TLR2, which 
is localized to the plasma membrane, senses the viral gH/gL and gB glycoproteins upon 
virion binding to the cell surface (Leoni et al., 2012).  In neonatal mice, TLR2 signaling 
in response to HSV infection of the brain produces an inflammatory response that leads 
to monocyte infiltration and lethal encephalitis (Kurt-Jones et al., 2004).  However, TLR2 
plays a protective role when mice are infected with HSV by intraperitoneal injection 
(Sorensen et al., 2008).   
HSV is also sensed in endosomal compartments by TLR3 (Zhang et al., 2007) 
and TLR9 (Lund et al., 2003), which recognize dsRNA and unmethylated CpG rich DNA, 
respectively.  Individuals with mutations in the TLR3 pathway show increased sensitivity 
to HSV-1 infection, indicating this pathway is important for the control of HSV (Casrouge 
et al., 2006; Lafaille et al., 2012; Zhang et al., 2007).  The most potent producers of IFN 
in response to HSV-1 infection are activated plasmacytoid dendritic cells, conventional 
dendritic cells, and macrophages (Hochrein et al., 2004).  Plasmacytoid dendritic cells, 
which are dedicated to antigen sampling in peripheral tissues, recognize infected 
epithelial cells through endocytosis.  The internalized viral DNA activates TLR9 in 
endosomal compartments, leading to the induction of type I IFNs and other antiviral 
gene products (Krug et al., 2004). 
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Members of the RLR family of receptors sense viral RNA that accumulates in the 
cytoplasm of HSV infected cells.  MDA5 has been shown to be important in the 
induction of an inflammatory response in response to HSV in primary human 
macrophages (Melchjorsen et al., 2010).  It has also been reported that RIG-I is 
involved in sensing HSV-1, although indirectly through the RNA Pol III DNA sensor 
(Chiu et al., 2009).  This sensor transcribes AT-rich DNA into 5ʼ triphosphate-containing 
RNA, which is subsequently recognized by RIG-I.   The importance of the RNA Pol III 
sensing pathway in HSV infection is unclear, as others have found it to be dispensable 
for the production of inflammatory cytokines during infection (Melchjorsen et al., 2010; 
Unterholzner et al., 2010).  
Herpesviral DNA is a potent activator of a type I IFN and inflammatory cytokine 
response.  Both HSV-1 and HCMV genomic DNA can induce IFN! expression when 
transfected into mouse embryonic fibroblasts (Ishii et al., 2006).  This DNA-dependent 
response to HSV-1 was later shown to be independent of TLR9, suggesting the 
existence of an additional DNA sensing mechanism (Rasmussen et al., 2007).  Since 
these initial observations, several cytosolic DNA sensors have been described with 
varying importance in sensing HSV infection.  While transient knockdown of the first 
identified cytosolic DNA sensor DNA-dependent activator of IRFs (DAI) was shown to 
be important in the response to HSV (Takaoka et al., 2007), DAI -/- mice were 
subsequently shown to respond normally to infection, suggesting the protein is 
dispensable or redundant in mice (Wang et al., 2008).  In addition, several members of 
the DExD/H helicase family, including DHX9 (Kim et al., 2010), DHX36 (Kim et al., 
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2010), and DDX41 (Zhang et al., 2011) have also been identified as cytosolic DNA 
sensors of HSV-1 infection in plasmacytoid dendritic cells and myeloid dendritic cells, 
respectively.  
Recently, a member of the PYHIN (Pyrin and HIN200 domain-containing) family 
of proteins was described as a cytosolic DNA sensor.  Interferon inducible protein 16 
(IFI16) was identified as a protein that immunoprecipitated with biotinylated 
immunostimulatory vaccinia viral DNA (Unterholzner et al., 2010).  Transient knockdown 
of the mouse ortholog p204 in RAW246.7 macrophages decreased the expression of 
type I IFNs in response to HSV-1 infection.  Subsequent work in human corneal 
epithelial cells confirmed the involvement of IFI16 in the translocation of IRF-3 to the 
nucleus and the production of a chemokine, CXCL10, in response to HSV-1 infection 
(Conrady et al., 2012).   
The multitude of DNA sensors that have been implicated in recognizing HSV-1 
infection has complicated our understanding of this cellular process.  Many different cell 
types have been used to investigate intracellular DNA sensing and it is likely that the 
components used for detection of foreign DNA are cell-type dependent.  Interestingly, a 
majority of cytosolic DNA sensing pathways have been shown to be dependent on 
stimulator of interferon genes (STING), an endoplasmic reticulum (ER) resident adaptor 
protein that is involved in the activation of IRF-3 (Ishikawa and Barber, 2008; Ishikawa 
et al., 2009).  Therefore, while the sensing components differ in a cell type-dependent 
manner, the functional response to HSV DNA appears to be the same. 
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1.5.2 HSV Evasion of Innate Immunity  
The innate immune response is important for controlling HSV-1 replication, as 
demonstrated by the increased susceptibility of IFNAR deficient mice to HSV-1 infection 
(Leib et al., 1999).  In addition, pre-treatment of cells with IFN inhibits HSV-1 immediate-
early gene expression in a dose-dependent manner (Altinkilic and Brandner, 1988), 
suggesting that the induction of an antiviral state in neighboring cells can inhibit virus 
spread.  The highly ubiquitous nature of this virus and its ability to spread to secondary 
tissues argues that HSV-1 employs means to evade the host immune response.    
HSV-1 infection induces an IRF-3-dependent type I IFN and ISG response in 
human fibroblasts in the absence of viral gene expression (Everett et al., 2008b; 
Mossman et al., 2001; Preston et al., 2001).  The induction of these effector molecules 
is potently inhibited by viral gene expression, suggesting that a viral protein inhibits this 
response.  Like many large DNA viruses, HSV-1 encodes multiple proteins that have 
been implicated in host immune evasion.  For instance, the ICP34.5 late gene product 
was recently reported to block type I IFN production by negatively regulating the 
phosphorylation of IRF-3 by TBK1 (Ma et al., 2012; Verpooten et al., 2009).  However, 
infection with an ICP4 deletion mutant, which is restricted to IE gene expression 
(DeLuca et al., 1985), did not result in the induction of ISGs (Mossman et al., 2001), 
implicating an immediate-early protein in inhibiting IRF-3 signaling.  
  Using a panel of HSV-1 mutants, Eidson et al (2002) demonstrated that the ICP0 
immediate-early protein could inhibit ISG induction during infection. A virus that 
expressed no viral gene products (d109) due to mutations within the five immediate-
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early genes robustly induced ISG54 expression, while infection with the ICP0-
expressing d106 virus inhibited this response (Eidson et al., 2002).  Furthermore, the 
ICP0-dependent inhibition of ISG54 induction was, in part, dependent on a functional 
proteasome, indicating that ICP0 may promote the degradation of a cellular factor 
involved in the activation of IRF-3.  While proteasome-dependent degradation of cellular 
proteins is a common immune evasion strategy adopted by viruses [reviewed in 
(McInerney and Karlsson Hedestam, 2009)], preliminary studies could not detect ICP0 
RING finger-mediated degradation of any known IRF-3 pathway components (Lin et al., 
2004).  
 Our lab has previously demonstrated that ICP0 expression promotes the 
increased turnover of Sendai virus (SeV) activated IRF-3 (Melroe et al., 2004).  
However, this phenotype does not fully explain ICP0ʼs inhibitory activity because it 
occurs several hours following IRF-3 nuclear accumulation.  We also observed an ICP0-
dependent intranuclear relocalization of IRF-3 (Melroe et al., 2007), indicating that ICP0 
may affect IRF-3 signaling through alternative mechanisms. 
 
1.6 Intrinsic Resistance to Viral Infection 
 In addition to the activation of the innate immune response described above, 
viruses are also subject to a constitutively expressed resistance mechanism termed 
intrinsic immunity or intrinsic antiviral resistance (Bieniasz, 2004).  Unlike innate 
immunity, which requires de novo protein synthesis to mediate its effects, intrinsic 
antiviral resistance involves constitutively expressed proteins that act directly on viruses 
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during infection.  These innate and intrinsic responses are closely linked however, as 
many intrinsic mediators can be upregulated by type I interferon production.  This 
response has been extensively investigated in the context of retroviral infection and 
several cellular proteins have been implicated in the restriction of these viruses 
[reviewed in (Bieniasz, 2004; Blanco-Melo et al., 2012)]. 
 
1.6.1 The Role of ND10 in Intrinsic Antiviral Resistance to HSV 
The most well characterized intrinsic antiviral response to herpesvirus infection 
involves the action of promyelocytic leukemia protein nuclear bodies (PML NB), also 
known as nuclear domain 10 (ND10).  These dynamic subnuclear domains are made up 
of a variety of cellular proteins, and have been implicated in diverse cellular processes, 
including gene expression, DNA damage, apoptosis, and aging (Lallemand-Breitenbach 
and de The, 2010).  As suggested by the name, PML represents a major component of 
these domains and is important for the recruitment of the constitutive ND10 components 
Sp100 and hDaxx. The formation of ND10 requires the SUMOylation of PML because 
mutational alteration of the known PML SUMOylation sites results in a failure to recruit 
Sp100 and hDaxx to these domains (Ishov et al., 1999; Zhong et al., 2000).  
Furthermore, cells deficient in the lone SUMO E2 enzyme, ubc9, show dramatic defects 
in ND10 number and localization (Nacerddine et al., 2005).  
During HSV-1 infection, ND10 components accumulate de novo in the nucleus at 
sites near incoming viral DNA (Everett and Murray, 2005; Everett et al., 2004b).  This 
response is not observed in wild-type virus infection as expression of ICP0 rapidly 
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disrupts ND10 by promoting the degradation of PML and Sp100 (Chelbi-Alix and de 
The, 1999).  The recruitment of these proteins to viral DNA is associated with the 
repression of ICP0-null virus replication in human fibroblasts as demonstrated by an 
increase in ICP0-null virus gene expression and replication upon individual knockdown 
of PML, Sp100, or hDaxx (Everett et al., 2008a; Lukashchuk and Everett, 2010).  
Simultaneous knockdown of these proteins indicated that ND10 components act 
cooperatively to repress herpesvirus infection, but are not responsible for the full defect 
in ICP0-null virus replication (Glass and Everett, 2012).  Although it remains unclear 
how these proteins repress viral gene expression during infection, recent studies 
indicate they may be involved in the epigenetic repression of viral DNA (Kim et al., 
2011; Shalginskikh et al., 2013).     
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Chapter Two: HSV-1 inhibits an antiviral response through the ICP0-dependent 
sequestration of IRF-3 from cellular promoters 
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Abstract 
The interferon regulatory factor 3 (IRF-3) pathway is a critical component of 
cellular innate immunity and is important for the induction of type I interferons in 
response to virus infection.  Herpes simplex virus 1 (HSV-1) activates IRF-3 signaling 
when viral protein synthesis is blocked, and viral gene expression inhibits this cellular 
response.  We found that HSV-1 ICP0 induced the relocalization of active IRF-3 to 
nuclear foci and enhanced turnover of this protein.  To study the mechanism of ICP0ʼs 
effects on IRF-3 we measured IRF-3 responsive gene expression in the presence of 
transfected WT-ICP0 or a RING-finger mutant plasmid.  Expression of ICP0 inhibited 
TBK1-activated endogenous IFN! expression, indicating ICP0 is sufficient to inhibit IRF-
3 signaling.  Using a constitutively active IRF-3 construct, we found that both WT and 
RING finger mutant ICP0 inhibited the expression of IRF-3 responsive genes, 
suggesting that ICP0 inhibits IRF-3 independently of its E3 ubiquitin ligase activity.  
Infection with a HSV-1 RING finger mutant virus stabilized IRF-3 protein levels in cells 
co-infected with Sendai virus (SeV), but did not increase IRF-3 responsive gene 
expression, consistent with our transfection results.  We also used chromatin 
immunoprecipitation to examine IRF-3 binding to endogenous promoters during co-
infection with SeV and HSV-1 d106, which only expresses nuclear-retained ICP0, or co-
infection with SeV and the HSV-1 d109 virus, which expresses no viral gene products. 
Infection with the d106 virus, but not d109, inhibited IRF-3 binding to the IFN-", ISG56, 
and ISG54 promoters at early times post-infection and prior to the degradation of IRF-3.  
Together, these results argue that ICP0-mediated degradation of IRF-3 is not involved in 
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the inhibitory activity of ICP0 and suggest that ICP0 inhibits this antiviral response by 
sequestering IRF-3 away from host chromatin. 
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Introduction 
The cell-based innate immune response is a critical aspect of host immunity and 
provides a first line of defense against viral infection.  A key outcome of this response is 
the production of pro-inflammatory cytokines, chemokines, and type I interferons (IFNs), 
which act to restrict virus replication at the site of infection and mobilize the adaptive 
immune response to promote viral clearance.   Secreted type I IFNs act in an autocrine 
and paracrine manner to upregulate the expression of IFN-stimulated genes (ISGs), 
which are integral components of the antiviral response.  However, expression of ISGs 
does not strictly rely on the type I IFN signaling pathway, as a subset of these proteins 
can be induced in the absence of de novo cellular gene expression (Bandyopadhyay et 
al., 1995; Mossman et al., 2001). 
This aspect of innate immunity is controlled by a variety of germline-encoded 
pattern recognition receptors (PRRs) that recognize conserved microbial products and 
subsequently activate intracellular signaling cascades to induce IFN and ISG 
expression.  In many cell types, the induction of these genes is dependent on interferon 
regulatory factor 3 (IRF-3), which is normally localized to the cytoplasm in an 
autoinhibited conformation (Lin et al., 1999).  However, virus-induced phosphorylation of 
IRF-3 displaces the autoinhibitory domain (Lin et al., 1998), allowing protein 
dimerization, translocation to the nucleus, and association with the coactivator 
CBP/p300, which is recruited to the promoters of IRF-3 responsive genes (Lin et al., 
1998; Weaver et al., 1998; Yoneyama et al., 1998). 
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The importance of IRF-3 in the control of viral replication is emphasized by the 
increased susceptibility of IRF-3 deficient mice to viral infections (Sato et al., 2000). 
Accordingly, this pathway has been identified as a major target of viral inhibition.  Many 
viruses express immunomodulatory proteins that counteract the induction of antiviral 
genes by inhibiting the IRF-3 pathway, and viral proteins have been identified that target 
each of the stages of IRF-3 activation, including phosphorylation, dimerization, and 
association with CBP/p300 (Ren et al., 2011).  In addition, several viral proteins inhibit 
the induction of IFN by promoting IRF-3 degradation (Bauhofer et al., 2007; Hilton et al., 
2006; Yu and Hayward, 2010).  
Herpes simplex virus 1 (HSV-1) is a ubiquitous human pathogen associated with 
a variety of maladies ranging from self-limiting herpetic lesions to ocular keratitis and 
herpes simplex encephalitis.  The life cycle of this virus is biphasic and consists of an 
initial lytic cycle of replication in epithelial cells followed by the establishment of a life-
long latent infection in enervating sensory neurons.  The type I IFN response inhibits the 
replication of HSV-1 at the primary site of infection and spread to the transgeminal 
ganglia (TG), as demonstrated by an increase in peripheral and TG virus titers in 
CD118-/- mice infected via corneal scarification (Conrady et al., 2011).  Furthermore, a 
direct correlation has been observed between virus replication in the periphery and the 
number of viral genomes present during latency (Thompson and Sawtell, 2000). 
Together these studies indicate that HSV-1 must overcome an antiviral response in vivo 
in order to replicate and then spread from the primary site of infection to secondary 
tissues. 
! #(!
The ability of HSV-1 to induce and inhibit the antiviral response has been 
investigated using cell culture models of lytic infection.  HSV-1 is intrinsically capable of 
activating IRF-3 and ISG expression in certain cell types;  however, this response is 
diminished upon viral gene expression, indicating that viral immune evasion 
mechanisms exist (Mossman et al., 2001; Preston et al., 2001).  Several reports have 
implicated the viral immediate-early ICP0 protein in the inhibition of IRF-3 signaling, 
although its mechanism of action has remained unclear (Eidson et al., 2002; Lin et al., 
2004; Melroe et al., 2004).  We have previously examined the inhibition of Sendai virus 
(SeV) induced IFN! expression in response to HSV-1 and observed both an ICP0-
dependent nuclear relocalization and degradation of IRF-3 during infection (Melroe et 
al., 2004; Melroe et al., 2007).  The relative importance of these two phenotypes in 
inhibiting IRF-3 activity has not been investigated. 
In this study, we further characterized the reported ICP0-mediated inhibition of 
IRF-3 by transfection and infection experimental approaches.  Our results indicate that 
HSV-1 infection controls IRF-3 responsive gene expression by sequestering IRF-3 
rather than by promoting IRF-3 degradation.  
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Materials and Methods 
 
Cell culture and Viruses.  Human endometrial adenocarcinoma (HEC-1B), human 
osteosarcoma (U2OS), and African green monkey kidney epithelial (Vero) cell lines 
were obtained from American Type Culture Collection.  Cells were grown in DMEM 
supplemented with 5% heat-inactivated fetal bovine serum and 5% heat-inactivated 
bovine calf serum, 2mM L- glutamine, streptomycin, and penicillin in a humidified 5% 
CO2 atmosphere at 37o C.  
The SeV Cantel strain was obtained from Charles River laboratories (Wilmington, 
MA).  HSV-1 wild-type KOS strain was propagated and titered on Vero cells.  The ICP0-
null (7134) and the ICP0-rescued (7134R) viruses were propagated and titered in 
parallel on U2OS cells (Cai and Schaffer, 1989).  The ICP0-RING finger mutant virus 
(KOS.RFm) and its corresponding rescued virus (KOS.RFr) were constructed as 
previously described by homologous recombination into the ICP0-null 7134 virus (Cai 
and Schaffer, 1989).  Briefly, infectious ICP0-null 7134 viral DNA was co-transfected 
into U2OS cells with a linearized plasmid containing ICP0 flanking regions as well as 
mutations within the ICP0 protein (pICP0 RFm).  These cells were harvested at three 
days post-transfection, freeze-thawed, and dilutions were plated on U2OS cells to 
isolate plaques.  An agarose overlay containing X-Gal was used to distinguish 
recombinant plaques that did not express beta-galactosidase.  White plaques 
underwent three rounds of purification before viral DNA was harvested.  The ICP0 RING 
finger domain was amplified, and mutations were confirmed by restriction endonuclease 
digestion and sequencing.  The KOS.RFm infectious viral DNA and a WT ICP0 
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linearized plamid were used to construct the KOS.RFr virus in a similar manner.  Virus 
stocks were grown and titered on U2OS cells. 
 
Virus infections. Viruses were diluted in cold phosphate-buffered-saline (PBS) 
containing 0.1% glucose and 1% heat-inactivated BCS.  Cells were infected at the 
stated MOI for 1h at 37° C, washed twice with PBS and overlaid with DMEM containing 
1% heat inactivated BCS.  Infected cells were incubated at 37° C for the indicated 
length of time. 
 
Plasmids. The ICP0 expression vector (pICP0) contains 4.6 kb of DNA derived from the 
long terminal repeat of the HSV-1 genome cloned into the pUC18 vector (Thermo-
Scientific).  This was constructed through several subcloning steps.  Briefly, a 6.5 kb 
SacI-PstI fragment was cloned from the pSG28 plasmid (Goldin et al., 1981) into pUC18 
(pICP0 6.5) followed by subcloning of the 4.6 kb EcoRI-HpaI fragment of pICP0 6.5 into 
the EcoRI-HincII site of pUC18.  The pICP0 RFm plasmid was constructed by 
sequential PCR mutagenesis of the XhoI-KpnI fragment of pICP0 to introduce C116G 
and C156A amino acid mutations.  The predicted DNA sequence was confirmed and the 
fragment was introduced into pICP0.  The Flag-TBK1 and pIRF-35D constructs were 
kindly provided by Dr. Katherine Fitzgerald (University of Massachusetts). 
 
Transfection.  HEC-1B cells were plated in 6-well plates to ensure 50% confluency on 
day of transfection.  A total of 1µg of DNA was transfected into cells using Effectene 
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reagent (Qiagen) and media was changed at 6 hours post transfection (hpt).  Cells were 
assayed at 36 hpt for RNA or protein expression. 
 
Cellular RNA analysis by qRT-PCR.  Total RNA was extracted from cell monolayers 
using Trizol reagent (Invitrogen) and 1µg of RNA was DNase-treated with the DNA-free 
kit (Ambion).  0.5ug of DNAse-free RNA was then reverse-transcribed using the iScript 
cDNA synthesis kit (Biorad) and quantified by real-time PCR (qPCR) using Power SYBR 
Green PCR master mix and a Prism 7300 sequence detection system (Applied 
Biosystems).  PCR reactions were carried out in duplicate, and relative copy numbers 
were determined by comparison with standard curves.  Mock reverse-transcribed 
samples were included as negative controls.  Transcript levels were normalized to $-
actin and made relative to mock-infected samples.  
 
Western blots.  Cells were lysed in 1x Sample Loading Buffer (80mM Tris pH 6.8, 
10.0% glycerol, 2.0% SDS, 0.01% bromophenol blue) and boiled at 100o C prior to being 
resolved on NuPAGE® 4-12% Bis Tris Gels (Invitrogen).  Proteins were transferred 
overnight to PVDF membranes and blocked with 5% milk in PBS.  Membranes were 
probed with primary antibody at 4o C, washed with PBS containing 0.05% Tween 20 and 
incubated in secondary antibody for 1h at room temperature.  Membranes were washed 
three times to remove unbound antibody and were developed using SuperSignal West 
Pico Chemiluminescent Substrate (Pierce Biotechnology).   
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Indirect immunofluorescence.  HSV-1 infected Vero cells grown on coverslips were 
fixed with 2% formaldehyde, permeabilized with 0.5% NP40, and blocked in 5% normal 
goat serum.  Fixed cells were incubated with antibodies for 30 min at 37°C and washed 
twice with PBS containing 0.05% Tween 20 followed by one wash with PBS.  An Alexa 
Fluor 594-conjugated secondary antibody was incubated with cells for 2h at 25°C.  The 
coverslips were washed as above and mounted in ProLong Gold antifade reagent 
(Invitrogen).  Images were acquired using an Axioplan 2 microscope (Zeiss) with a 63X 
objective and Hamamatsu CCD camera (Model C4742-95).  Images were arranged in 
figures using Adobe Photoshop CS4 (Adobe Systems).   
 
Isolation, amplification and digestion of viral DNA.  Total cellular DNA was 
harvested using the Generation Capture Column Kit (Qiagen) at 4hpi.  The RING finger 
domain of ICP0 was amplified using the High Fidelity polymerase reagent (Roche).  The 
thermal cycling parameters were as follows:  1 cycle for 5 min at 37°C, followed by 35 
cycles of 30 sec at 94°C, 30 sec at 49°C, and 90 sec at 72°C, followed by 1 cycle for 5 
min at 72°C.  The PCR product was digested with 10 units of Msc1 (New England 
Biolabs) diluted in appropriate buffer for 2h at 37oC.  6x loading dye (30% v/v glycerol, 
0.25% bromophenol blue) was added to digested DNA and resolved on a 2% agarose 
gel.  
 
Chromatin Immunoprecipitation.  Cells were incubated with 1% formaldehyde for 15 
min to cross-link the chromatin at 5 hpi.  Cells were washed twice with PBS and scraped 
into PBS containing 1x Complete protease inhibitor tablets (Roche Diagnostics).  Cells 
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were resuspended in RIPA lysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 
0.5% Na deoxycholate, 0.1% SDS) containing protease inhibitors and incubated on ice 
for 30 min.  The samples were sonicated using a Biorupter 200 (Diagdnode) for eight 
cycles of 30s on 30s off for 5 min.  This yielded DNA fragments averaging 500 bp in 
length.  The samples were clarified by centrifugation at 13,000g at 4°C for 10 min.  The 
clarified chromatin was diluted in ChIP dilution buffer (150 mM NaCl, 10 mM Na2PO4, 2 
mM EDTA, 1.1% Triton, 0.1% SDS, 1 mM PMSF) pre-cleared with a salmon sperm 
DNA/protein A-agarose slurry for 1 h at 4°C.  At this point, 1% of the total volume was 
removed and reserved as the input.  Immunoprecipitation was carried out at 4°C 
overnight with 3 µg rabbit immunoglobulin G (IgG; Millipore) as the negative control or 3 
µg anti-IRF-3 antibody (FL425, Santa Cruz Biotechnology). 
Immunocomplexes were collected by incubation with a salmon sperm DNA/ 
protein A-agarose slurry for 1 h at 4°C with rotation.  Beads were washed for 5 min at 
4°C with rotation, twice with ChIP dilution buffer, twice with lithium chloride wash buffer 
(0.25 M LiCl, 1% NP-40, 0.7% sodium deoxycholate, 1 mM EDTA, and 10 mM Tris-HCl, 
pH 8.1) and twice with Tris-EDTA buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA).  The 
DNA-protein complexes were eluted by the addition of 200 µl of elution buffer (0.75% 
SDS, 0.1 M NaHCO3) preheated to 65°C, rotating for 10 min at room temperature, 
incubating for 10 min at 65°C, and rotating for a final 10 min at room temperature.  NaCl 
was added to a final concentration of 0.2 M to both the eluates and the inputs, and the 
samples were incubated at 65°C for 5 h in the presence of 1 µg RNase A (Ambion).  
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The samples were then digested with proteinase K (Qiagen), and the DNA was purified 
using a QIAquick PCR purification kit (Qiagen). 
 
Antibodies.  Antibodies used in Western blot experiments were mouse anti-ICP0 
(1:1000, EastCoast Bio), mouse anti-FLAG (1:1000, abcam), mouse anti-GAPDH 
(G041, 1:5000, Applied Biological Materials), mouse anti-USP7 (C-2, 1:1000, Santa 
Cruz Biotechnology), and mouse anti-IRF3 (SL-12, 1:1000, Santa Cruz Biotechnology).  
Horse Radish Peroxidase-conjugated goat secondary antibodies were used at 1:10,000 
(Santa Cruz Biotechnology). 
For the indirect immunofluorescence study, anti-ICP0 primary antibody (1:150, 
EastCoast Bio) and goat anti-mouse Alexa 594 secondary antibody (1:500, Jackson 
ImmunoResearch) were used. 
 
Primers. 
Name Use Primer Sequences 
IFN" qRT-PCR 5ʼ-AAACTCATGAGCAGTCTGCA-3ʼ 
5ʼ-AGGAGATCTTCAGTTTCGGAGG-3ʼ 
 
ISG56 qRT-PCR 5ʼ-AAGGCAGGCTGTCCGCTTA-3ʼ 
5ʼ-TCCTGTCCTTCATCCTGAAGCT-3ʼ 
 
ISG54 qRT-PCR 5ʼ-ACGGTATGCTTGGAACGATTG-3ʼ 
5ʼ-AACCCAGAGTGTGGCTGATG-3ʼ 
 
IL-6 qRT-PCR 5ʼ-ACCGGGAACGAAAGAGAAGC-3ʼ 
5ʼ-CTGGGAGTTCCAGGGCTAAG-3ʼ 
 
#-actin qRT-PCR 5ʼ-CACCGCCGCATCCTCCTCTTC-3ʼ 
5ʼ-GTGGTGCCGCCCGACAGC-3ʼ 
 
IFN" 
promoter 
qPCR 5ʼ-ACTGAAAGGGAGAAGTGAAAGTGGA-3ʼ 
5ʼ-TGCCAGAGCAAAGGCTTCGAAAGG-3ʼ 
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ISG56 
promoter 
qPCR 5ʼ-AGTTTCACTTTCCCCTTTCGC-3ʼ 
5ʼ-ATCCTTACCTCATGGTTGCTG-3ʼ 
 
ISG54 
promoter 
qPCR 5ʼ-AATGTCCCCAGACCCATCTTT-3ʼ 
5ʼ-CCGGAGCTGAGTTGTGATCA-3ʼ 
 
ICP0 
C116G 
mutagenesis 5ʼ-GACGAGGGCGACGTGGGAGCCGTGTGCACGGATG-3 
5ʼ-CATCCGTGCACACGGCTCCCACGTCGCCCTCGT-3ʼ 
 
ICP0 
C156A 
mutagenesis 5ʼ-CGCAACACCTGCCCGCTGGCCAACGCCAAGCTGGTGTAC-3ʼ 
5ʼ-GTACACCAGCTTGGCGTTGGCCAGCGGGCAGGTGTTGCG-3 
ʼ 
ICP0 
RING 
Amp  
PCR 5ʼ-TTGCCCGTCCAGATAAAGTC-3ʼ 
5ʼ-AGACCACCTTTGGTTGCAGA-3ʼ 
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Results 
HSV-1 ICP0 contributes to the inhibition of SeV induced IFN! expression and is 
required for inhibition of ISG54.  Previously, our lab reported the effect of HSV-1 on 
the induction of type I interferon (IFN) in Sendai virus (SeV) coinfected HEC-1B cells. 
These cells lack a functional type I IFN receptor (Wathelet et al., 1988) and allow the 
quantification of IFN and ISG expression without the confounding positive feedback 
loops observed with IFN induction.  Using semi-quantitative RNAse protection assays, 
we observed that HSV-1 infection could inhibit the expression of IFN" mRNA induced by 
SeV (Melroe et al., 2004).  While a HSV-1 virus that only expressed ICP0 was sufficient 
to inhibit IFN" production in response to SeV, ICP0-null viruses also retained their ability 
to inhibit IFN" expression (Melroe et al., 2004), arguing that ICP0 was not necessary to 
inhibit the induction of IFN".  In contrast, others have reported an increase in the 
expression of IRF-3 responsive genes during ICP0-null virus infection (Lin et al., 2004; 
Paladino et al., 2010).  To reconcile these reports with our own results, we investigated 
HSV-1 mediated inhibition of SeV induced IFN" expression using quantitative RT-PCR 
(qRT-PCR), which would allow us to identify subtle differences in cellular gene 
expression not detected in our original report. 
To this end, HEC-1B cells were coinfected with SeV and either an ICP0-null virus 
(7134) or its rescue (7134R) at an MOI of 20.  Total RNA was harvested from cells at 5 
hours post infection (hpi) and IFN", ISG56, and ISG54 mRNAs were measured by qRT-
PCR.  Infection with SeV alone robustly induced the expression of these genes, while 
wild-type HSV-1 significantly inhibited their induction (Figure 2.1, A-C), consistent with  
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Figure 2.1: Deletion of ICP0 enhances antiviral gene expression.  Total RNA was 
harvested at 5 hpi from HEC-1B cells infected with SeV alone or in conjunction with 
HSV-1 7134 or 7134R viruses.  The harvested RNA was analyzed by qRT-PCR for the 
presence of (A) IFN", (B) ISG56, (C) ISG54, an (D) IL-6 mRNA.  Cellular RNA levels 
were normalized to #-actin levels and made relative to mock-infected samples.  Results 
are an average of four (IFN" and ISG56) or three (ISG54 and IL-6) independent 
experiments and error bars represent the standard error of means. *p%.05, *** p%.001 
(Studentʼs t test). 
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HSV-1 inhibiting SeV-induced innate immune signaling.  In contrast to our previously 
published results, we observed an increase in IFN" (5-fold) and ISG56 (2-fold) 
expression in 7134-infected cells when compared to 7134R infection.  While this 
increase was subtle, and did not account for the full inhibition observed, the change in 
gene expression was statistically significant (IFN") or reproducible (ISG56).  In contrast, 
HSV-1 infection was unable to inhibit the induction of ISG54 in the absence of ICP0 
(Figure 2.1C).  These results indicated that the requirement for ICP0 to inhibit SeV 
induced antiviral gene expression was dependent on the gene examined and confirmed 
that HSV-1 employs multiple mechanisms to inhibit IFN" expression.  
Expression of IFN" is dependent on the activation of IRF-3;  however, this protein 
alone is not sufficient to induce IFN" expression.  Instead, full activation of the IFN" 
promoter relies on the synergistic activity of several transcription factors, including NF-
#B, IRFs, and ATF-2/c-Jun (Wathelet et al., 1998).  In contrast, IRF-3 is sufficient but 
not necessary to induce ISG56 expression, while being both necessary and sufficient to 
induce ISG54 (Andersen et al., 2008; Grandvaux et al., 2002).  Interestingly, we 
observed a more robust inhibition of IFN" expression (35-fold) than ISG56 (11-fold) or 
ISG54 (4-fold) in wild-type HSV-1-infected cells (Figure 2.1 A-C), suggesting that HSV-1 
may affect the activity of transcription factors other than IRF-3.  We therefore tested 
whether HSV-1 could inhibit SeV induced NF-#B signaling by examining the induction of 
an NF-#B responsive gene in our coinfection system.  Interestingly, we observed a 
significant decrease in the induction of Interleukin-6 (IL-6) mRNA in HEC-1B cells 
coinfected with SeV and 7134R (Figure 2.1D).  Infection with the ICP0-null 7134 virus 
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also inhibited the induction of IL-6, but to a lesser extent than 7134R.  Together these 
results argue that in addition to its ability to inhibit IRF-3-dependent gene expression, 
HSV-1 inhibits SeV induction of NF-#B-dependent genes.  Furthermore, our results 
indicate that ICP0 expression accounts for a portion of this inhibition of NF-#B signaling.  
 
HSV-1 ICP0 is sufficient to inhibit IFN! expression.  The experiments above showed 
that ICP0 expression was necessary to inhibit a portion of IFN" induction;  however, it 
was unclear whether ICP0 was sufficient to inhibit this response.  We previously 
reported that the d106 virus, which expresses ICP0 but no additional immediate-early 
genes, was capable of inhibiting IFN! production (Eidson et al., 2002; Melroe et al., 
2004);  however, experiments with this virus do not rule out ICP0 acting in concert with 
incoming tegument proteins to mediate this response.  To test whether ICP0 was 
sufficient to inhibit IFN" expression in the absence of other viral genes, we examined 
the induction of IFN" in the presence of ICP0 expressed from a transfected plasmid.  
HEC-1B cells were transfected with a FLAG-TBK1 construct and increasing doses of an 
ICP0 expression plasmid.  Overexpression of FLAG-TBK1 induced the expression of 
IFN" in comparison to empty vector-transfected cells (Mock), while ICP0 expression 
inhibited this induction in a dose-dependent manner (Figure 2.2A).  This indicated that 
ICP0 was sufficient to inhibit IFN" expression.  Cell lysates from transfected cells were 
also examined for TBK1, ICP0 and IRF-3 protein levels.  Interestingly, we observed an 
ICP0-dependent increase in the steady-state levels of FLAG-TBK1 (Figure 2.2B).  This 
result was not unexpected, as ICP0 has been reported to be a promiscuous  
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Figure 2.2: ICP0 expression is sufficient to inhibit IFN" expression.  HEC-1B cells 
were transfected with 500 ng pFLAG-TBK1 alone or co-transfected with either 200 or 
400 ng of pICP0.  The total amount of transfected DNA was brought up to 1000 ng with 
empty vector plasmid.  Total RNA or whole cell lysates were harvested at 36 hours post 
transfection and analyzed by (A) qRT-PCR for endogenous IFN" expression, or (B) 
western blot analysis using ICP0-, FLAG-, and IRF-3 specific antibodies.  Cellular 
GAPDH levels were used as a recovery and loading control.  Cellular RNA levels were 
normalized to #-actin levels and made relative to empty vector transfected (mock) 
samples.  qRT-PCR results are an average of two-independent experiments and error 
bars represent the standard error of means.  
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transactivator of HSV-1 and heterologous genes (Roizman et al., 2013), but suggested 
that our transfection results may underestimate the inhibitory activity of ICP0.  We also 
observed an ICP0-dependent decrease in the levels of endogenous IRF-3, consistent 
with the loss of activated IRF-3 reported during SeV coinfection with either wild-type 
HSV-1 or the ICP0-expressing d106 virus (Melroe et al., 2004; Melroe et al., 2007).  
While this result suggested that ICP0 was also sufficient to promote IRF-3 degradation, 
we cannot rule out that the increased turnover of IRF-3 was not due to the observed 
increase in TBK1 expression, as the cellular response to downregulate IRF-3 activity 
involves proteasomal degradation of the protein (Lin et al., 1998). 
 
Transfected ICP0 inhibits constitutively active IRF-3 in a RING finger–
independent manner.  ICP0 contains a C3HC4 zinc RING finger domain, which is 
responsible for the proteinʼs E3 ubiquitin ligase activity (Boutell et al., 2002). Disruption 
of this domain through mutational alteration inhibits the ability of ICP0 to promote the 
ubiquitination and subsequent degradation of target proteins.  Because expression of 
ICP0 induces the increased degradation of SeV activated IRF-3 during HSV-1 infection 
(Melroe et al., 2004), we asked whether the RING finger domain is necessary to inhibit 
IRF-3 activity.  To answer this question, we generated a mutant ICP0 plasmid (pICP0 
RFm) with two point mutations in the RING finger domain (C116G/C156A), which 
disrupts the catalytic activity of this protein (Lium and Silverstein, 1997; Vanni et al., 
2012).  Plasmids encoding wild-type or RING finger mutant ICP0 were then transfected 
into HEC-1B cells along with a constitutively active IRF-3 mutant (IRF-35D) and IRF-3 
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responsive gene expression was measured by qRT-PCR.  Wild-type ICP0 inhibited IRF-
35D-induced IFN", ISG56 and ISG54 expression in a dose-dependent manner (Figure 
2.3A-C), recapitulating the inhibitory phenotype observed in our SeV coinfection model.  
Furthermore, of the three genes examined, ICP0 had the greatest effect on the 
expression of IFN", possibly due to the ability of ICP0 to inhibit both IRF-3 and NF-#B 
signaling.  Although the extent of inhibition of these genes may appear modest (50-75% 
at highest ICP0 expression), western blot analysis of cell lysates from transfected cells 
revealed an ICP0-dependent increase in IRF-35D protein levels at lower levels of ICP0 
(Figure 2.3D), similar to what we observed when co-transfecting TBK1 and ICP0 in 
Figure 2.2B.  At the highest level of ICP0 expression we observed a decrease in IRF-
35D levels, suggesting that ICP0 may overcome the transactivation of IRF-35D 
expression.  These data indicated a possible underestimation of the inhibition provided 
by wild-type ICP0, consistent with the results reported in Figure 2.2.  
Surprisingly, we also observed a decrease in the expression of IFN", ISG56, and 
ISG54 in cells transfected with the RING finger mutant (Figure 2.3A-C), which did not 
transactivate IRF-35D or its own expression (Figure 2.3D), indicating that ICP0 can 
inhibit IRF-3 signaling though a RING finger-independent mechanism.  However, due to 
the observed differences in both ICP0 and IRF-3 protein levels in these transfection 
studies, a direct comparison of the inhibition mediated by wild-type ICP0 and the RING 
finger mutant was not possible.  Therefore, we cannot conclude what portion of ICP0 
activity relies on a functional RING finger domain.  Nevertheless, these results argue  
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Figure 2.3: ICP0 inhibits IRF-3 independently of RING finger domain.  HEC-1B cells 
were transfected with 400 ng pIRF35D alone or co-transfected with 200 to 600 ng of 
pICP0 or 600 ng pICP0 RFm.  Total transfected DNA was brought up to 1000 ng with 
empty vector plasmid DNA.  Total RNA or whole cell lysates were harvested at 36 hpt 
and analyzed by (A) qRT-PCR for endogenous IFN", ISG56, and ISG54, or (B) western 
blot analysis using ICP0- and IRF-3 specific antibodies.  Cellular GAPDH proteins levels 
were used as a recovery and loading control.  Cellular RNA levels were first normalized 
to #-actin levels and then to empty vector (mock) samples. 
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that ICP0 is capable of inhibiting IRF-3 activity through a RING finger-independent 
mechanism. 
 
Construction and validation of ICP0 RING finger mutant and rescued viruses.  
Due to the inherent difficulties in interpreting our ICP0 transfection studies, we next 
constructed an ICP0 RING finger mutant virus to examine the relative effect of the RING 
finger domain in inhibiting SeV activated IRF-3.  Our RING finger mutant virus 
(KOS.RFm) was constructed by homologous recombination between infectious ICP0-
null virus DNA and the pICP0 RFm plasmid, which contains complementary ICP0 
flanking sequence.  The successful recombination of this RING finger mutation 
introduced a novel Msc1 restriction site, which was confirmed by PCR amplification of 
the viral DNA and restriction endonuclease digestion (Figure 2.4A, Lane 5).  Digestion 
of the corresponding rescue virus (KOS.RFr) DNA did not result in cleavage of the 
amplified DNA (Figure 2.4A, Lane 3), indicating the construction of a successful 
genotypic rescue.   
We next examined these two viruses for known defects in ICP0 activity.  ICP0 
mutant viruses are restricted for growth in several cell lines, including Vero cells; 
therefore, we examined the replication of KOS.RFm and KOS.RFr in these cells.  
Consistent with a defect in ICP0 activity, we observed an approximate 3-log decrease in 
KOS.RFm viral yield in Vero cells compared to cells infected with the rescue virus or 
wild-type HSV-1 KOS strain (Figure 2.4B).  Moreover, the KOS.RFm virus was unable 
to promote the degradation of USP7, a well-characterized direct target of ICP0-mediated  
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Figure 2.4 
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Figure 2.4 (Continued): An ICP0 RING finger mutant virus is defective for ICP0-
dependent activities.  (A) Total DNA from KOS.RFm and KOS.RFr infected cells were 
harvested at 4hpi and the RING finger domain of ICP0 was amplified by PCR, digested 
with Msc1, and visualized on a 2% agarose gel with 1kb ladder.  (B) Vero cells were 
infected with wt-KOS, KOS.RFm or KOS.RFr viruses at an MOI of 0.1, harvested at 
48hpi and viral yields were determined by plaque assay on U2OS cells.  (C) Vero cells 
were mock-infected or infected with KOS.RFm or KOS.RFr at an MOI of 10 and whole 
cell lysates were harvested at 6 hpi and probed for ICP0, USP7 and GAPDH levels.  (D) 
Vero cells grown on coverslips were infected with KOS.RFm or KOS.RFr at an MOI of 
10.  Samples were fixed at 3 and 6hpi, stained for ICP0, and visualized by indirect 
immunofluorescence 
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ubiquitination (Canning et al., 2004), while the rescued virus efficiently promoted the 
loss of this protein (Figure 2.4C).  Finally, this mutation did not disrupt the ability of ICP0 
to form nuclear foci at early time-points in infection (Figure 2.4D, 3hpi).  However, ICP0 
expressed from KOS.RFm did not accumulate in the cytoplasm at late time-points in 
infection consistent with the growth defect observed in Vero cells (Figure 2.4D, 6hpi) 
and indicating a delay in viral DNA replication.  Together, these results argued that our 
KOS.RFm virus phenocopies previously described ICP0 RING finger mutant viruses 
(Canning et al., 2004; Everett, 1989; Lium and Silverstein, 1997), and that KOS.RFr 
successfully rescues the wild-type virus phenotype.   
 
HSV-1 ICP0 promotes IRF-3 degradation in a RING finger-dependent manner.  
The IRF-3 signaling pathway is subject to a negative cellular feedback mechanism 
following activation, which promotes the degradation of IRF-3 and limits the expression 
of type I IFN as observed by immunoblot analysis following RNA virus infection (Lin et 
al., 1998).  Previously, we have reported that ICP0 expression enhances the 
degradation of SeV activated IRF-3 (Melroe et al., 2004).  To determine whether the 
observed degradation of IRF-3 was dependent on ICP0 E3 ubiquitin ligase activity, we 
examined the steady state levels of SeV-activated IRF-3 during infection with our ICP0 
RING finger mutant virus. 
HEC-1B cells were coinfected with SeV and either KOS.RFm or KOS.RFr at an 
MOI of 20.  Cell lysates were harvested at 2, 4, 6, and 8 hpi and analyzed by western 
blot.  Consistent with previously published results (Melroe et al., 2004), the KOS.RFr 
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virus enhanced the loss of SeV activated IRF-3 as early as 4 hpi (Figure 2.5, lane 6 vs 
lane 5).  This phenotype was dependent on the RING finger activity of ICP0, as we did 
not observe an increase in IRF-3 degradation in KOS.RFm coinfected cells when 
compared to KOS.RFr coinfection or SeV infection alone (Figure 2.5, lane 6 vs lanes 5 
and 7).  Instead, we observed a stabilization of SeV-activated IRF-3 during coinfection 
with the ICP0 RING finger mutant virus, particularly at 6 and 8 hpi (Figure 2.5, lanes 10 
and 13).  Together, these results argued that HSV-1 enhances the degradation of SeV-
activated IRF-3 in an ICP0 RING finger-dependent manner but that in the absence of a 
functional RING finger domain, ICP0 inhibits the normal cellular turnover of IRF-3.    
 
HSV-1 ICP0 inhibits SeV-activated IRF-3 responsive gene expression 
independently of the RING finger domain.  In Figure 2.1 we observed an ICP0-
dependent inhibition of SeV-activated antiviral gene expression.  To test whether this 
inhibition was dependent on the RING finger activity of ICP0, we examined the induction 
of IRF-3 responsive genes during co-infection with SeV and either KOS.RFm or 
KOS.RFr.  At 5 hpi, RNA from co-infected cells was harvested and analyzed by qRT-
PCR.  We observed a significant reduction in SeV-induced IFN", ISG56, ISG54, and IL-
6 expression in KOS.RFr co-infected cells (Figure 2.6A-D), similar to our results with 
7134R infection in Figure 2.1.  Interestingly, we observed an increase in the expression 
of all four genes during KOS.RFm infection when compared to cells infected with 
KOS.RFr (Figure 2.5A-D), although the extent of this increase varied among the 
individual genes.  The increases in antiviral gene expression were comparable to the  
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Figure 2.5: KOS.RFm inhibits the ICP0-dependent enhanced degradation of IRF-3. 
HEC-1B cells were mock infected, infected with SeV [100 hemagglutinating units (HAU)] 
alone or co-infected with KOS.RFr or KOS.RFm at an MOI of 20.  Whole cell lysates 
were harvested at 2, 4, 6, and 8 hpi and probed for ICP0 and IRF-3 using specific 
antibodies.  Cellular GAPDH protein levels were used as a recovery and loading control.  
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induction observed during ICP0-null virus infection (Figure 2.1), suggesting that the 
RING finger domain accounts for the ICP0-dependent effect on gene expression.  
However, this observation is in direct conflict with our transfection data that implicated a 
RING finger-independent mechanism of action (Figure 2.3). 
One possible explanation to reconcile this difference may stem from the 
observed stabilization of IRF-3 during SeV coinfection with KOS.RFm (Figure 2.5).  In 
other instances, decreasing the cellular turnover of IRF-3 through modifications like 
ISGylation enhances antiviral gene expression (Shi et al., 2010).  Interestingly, we did 
not observe an increase in ISG54 expression during KOS.RFm co-infection over that of 
SeV infection alone (Figure 2.6C), indicating that the RING finger mutant inhibited any 
potential IRF-3 activity associated with protein stabilization.  In light of this observation, 
our results suggest that ICP0 can inhibit SeV-activated IRF-3 independently of the RING 
finger domain and IRF-3 degradation.  
 
ICP0 expression inhibits IRF-3 occupancy on cellular promoters prior to 
promoting the degradation of IRF-3.  Upon activation and accumulation in the 
nucleus, IRF-3 binds to specific DNA sequences in the promoter regions of cellular 
genes and recruits the CBP/p300 coactivator to promote their expression.  During HSV-
1 infection, ICP0 induces the intranuclear relocalization of SeV activated IRF-3 to ICP0 
foci prior to the detectable degradation of IRF-3 (Melroe et al., 2007).  Because the 
results of this study indicate that ICP0 inhibits IRF-3 independently of protein 
degradation, we hypothesized that ICP0 could inhibit the recruitment of IRF-3 to cellular  
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Figure 2.6:  KOS.RFm inhibits the expression of antiviral genes.  Total RNA was 
harvested at 5 hpi from HEC-1B cells infected with SeV alone or in conjunction with 
HSV-1 KOS.RFr or KOS.RFm viruses.  The harvested RNA was analyzed by qRT-PCR 
for the presence of (A) IFN", (B) ISG56, (C) ISG54, an (D) IL-6 mRNA.  Cellular RNA 
levels were normalized to #-actin levels and made relative to mock-infected samples. 
Results are an average of four (IFN" and ISG56) or three (ISG54 and IL-6) independent 
experiments and error bars represent the standard error of means. *p%.05, ** p%.01, 
***p%.001 (Studentʼs t-test). 
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promoters.  To test this hypothesis, we examined the ability of IRF-3 to associate with 
cellular DNA by chromatin immunoprecipitation (CHIP) during SeV co-infection with the 
HSV-1 d106 and d109 recombinant viruses.  The d106 virus expresses ICP0, but not 
ICP4, -22, -27, or -47 (Samaniego et al., 1998).  In contrast, the d109 virus does not 
express any viral immediate-early genes, including ICP0.  The d106 virus was 
previously used to investigate ICP0-mediated inhibition of IRF-3 (Eidson et al., 2002), 
and it recapitulates the ICP0-dependent phenotypes observed during wild-type HSV-1 
infection (Melroe et al., 2004; Melroe et al., 2007).   
HEC-1B cells were infected with SeV alone or co-infected with either d106 or 
d109 at an MOI of 20.  At 5 hpi, cells were fixed with formaldehyde and IRF-3-
associated DNA was immunoprecipitated with an IRF-3 specific antibody and analyzed 
by qPCR using promoter specific primer sets.  We observed a significant increase in 
IRF-3 association with the IFN", ISG56, and ISG54 promoters in SeV-infected cells 
compared to mock-infected cells (Figure 2.7A-C), consistent with the induction of IRF-3 
responsive gene expression at this time point (Figure 2.1 and 2.6).  Co-infection with 
d106, but not the d109 virus, significantly inhibited the amount of IRF-3 bound to these 
genes, suggesting that ICP0 expression inhibits IRF-3 recruitment to cellular promoters. 
 Infection with the d106 virus has also been shown to increase the degradation of 
IRF-3, but this phenotype is delayed compared to wild-type infection (Melroe et al., 
2004; Melroe et al., 2007).  To test whether the decrease in IRF-3 occupancy on cellular 
promoters observed during d106 infection correlates with a decrease in IRF-3 protein 
levels, we examined the steady state levels of this protein in lysates from our CHIP  
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Figure 2.7: ICP0 expression inhibits IRF-3 occupancy on cellular promoters. 
Chromatin immunoprecipitation assay measuring IRF-3 levels on cellular promoters. 
HEC-1B cells were mock infected, infected with SeV (100 HAU) alone or co-infected 
with d106 or d109 at an MOI of 20.  Cells were fixed at 5 hpi and chromatin was 
prepared and subjected to immunoprecipitation using IRF-3 or control rabbit IgG-
specific antibodies. Immunoprecipitated DNA was measured by qPCR using primers 
specific for the (A) IFN",  (B) ISG56, and (C) ISG54 gene promoters.  Data are 
presented as a percent of total DNA immunoprecipitated and values are the average of 
three independent experiments.  (D) Lysates from fixed samples were reverse cross-
linked and probed for ICP0, IRF-3, and GAPDH levels by western blot. 
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assays.  Infection with the d106 virus only slightly decreased the levels of IRF-3 
compared to cells infected with SeV alone or with d109 virus (Figure 1.7D);  however, 
not to the extent that would affect our CHIP analysis.  Together these results indicate 
that the decrease in IRF-3 occupancy observed during d106 infection cannot be 
explained by ICP0-dependent turnover of IRF-3, and argued for an ICP0-dependent 
mechanism that relies on sequestration rather than degradation of IRF-3. 
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Discussion 
In this study we further characterized the HSV-1-mediated inhibition of antiviral 
gene expression and the role of ICP0 in inhibiting this response.  We confirmed that 
HSV-1 employs multiple mechanisms to inhibit IFN" expression, but that inhibition of 
ISG54 expression relies solely on ICP0.  Prior to this study, we hypothesized that ICP0 
could inhibit IRF-3 activity through two distinct mechanisms: either through degradation 
of IRF-3 or through an ability to sequester the protein away from host chromatin.  Here 
we demonstrate that, although ICP0 promotes IRF-3 degradation in a RING finger-
dependent manner, this response is not necessary to inhibit IRF-3 responsive gene 
expression.  Instead, our results support a degradation-independent model that involves 
ICP0 sequestering IRF-3 from host chromatin. 
 
  
Inhibition of NF-#B and IRF-3 responsive genes by HSV-1.  HSV-1 infection inhibits 
both the expression of type I IFNs and ISGs to evade the host immune response.  Initial 
attempts to identify the specific viral gene product(s) necessary to inhibit the induction of 
these genes were unsuccessful, as deletion of individual immediate-early genes had no 
effect on the production of either IFN! or ISG56 (Melroe et al., 2004; Mossman et al., 
2001).  However, the expression of ICP0 during d106 infection was sufficient to inhibit 
IFN" expression, suggesting the failure of these initial studies was due to the virus 
encoding multiple proteins that inhibit type I IFN production (Melroe et al., 2004).  The 
study presented here confirms that ICP0 expression is mostly dispensable for the 
inhibition of both IFN" and ISG56 expression during HSV-1 infection, but was 
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unexpectedly necessary to inhibit ISG54 expression.  The differential requirement for 
ICP0 in the inhibition of these genes may be due to differences in the sufficiency of IRF-
3 in their activation.  It has become increasingly clear that the induction of antiviral 
genes can be regulated by many transcription factors, and while IRF-3 is required for 
IFN" expression, it is not sufficient to induce its activation (Agalioti et al., 2000; 
Andersen et al., 2008).  In contrast, IRF-3 is both necessary and sufficient to induce 
ISG54 expression.  Interestingly, while the ISG56 gene is frequently used as a readout 
for IRF-3 activity, our results indicate that the requirements for its induction in response 
to SeV differ from that of ISG54.  The exact nature of this difference remains unclear. 
During the examination of additional virus-induced genes we observed that HSV-
1 infection decreased the induction of IL-6, whose expression is dependent on NF-#B.  
Based on this observation, we hypothesize that a portion of the ICP0-independent 
inhibition of IFN" expression observed during HSV-1 infection may involve the inhibition 
of NF-#B.  HEC-1B cells do not induce an innate immune response to HSV-1 infection, 
even in the absence of viral gene expression (Melroe et al., 2004), indicating the targets 
of HSV-1 inhibition are within the signaling pathway that senses SeV infection in these 
cells.  During infection, SeV RNA replication intermediates are sensed by cytosolic RIG-I 
or endosomal TLR7 in a cell type- dependent manner (Kato et al., 2005; Lund et al., 
2004).  HEC-1B cells express both RIG-I and TLR7;  however, they do not respond to 
the TLR7 agonist Loxoribine (Aboussahoud et al., 2010), indicating that the response to 
SeV in these cells is mediated by RIG-I.  Therefore, the targets of HSV-1 inhibition are 
within the RIG-I pathway in HEC-1B cells.  
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The viral gene(s) that inhibit the NF-#B response observed here are relatively 
unknown.  Our results implicate ICP0 in inhibiting this response, but expression of this 
protein did not account for the full inhibition in IL-6 mRNA production.  Additional HSV-1 
proteins have been reported to inhibit NF-#B activity.  Deletion of the HSV-1 US11 
protein was recently shown to slightly inhibit SeV-induced IFN" expression at the step of 
RIG-I or MDA-5 activation (Xing et al., 2012).  However, in our SeV co-infection model 
we have not observed a difference in the phosphorylation of IRF-3 during HSV-1 
infection (Melroe et al., 2004), indicating that the effect on IL-6 production occurs 
downstream of MAVS in the NF-#B arm of the RIG-I signaling cascade (Figure 2.8).  
Recently, we have identified the US3 tegument protein as a modulator of NF-#B 
signaling, albeit in response to TLR2 activation (Sen et al., 2013).  Both the TLR2 and 
RIG-I pathways have considerable overlap in the signaling molecules used to activate 
NF-#B, including TRAF6, whose ubiqutination is inhibited by US3.  Therefore, it is 
conceivable that US3 might be involved in inhibiting the RIG-I-dependent pro-
inflammatory cytokine response through a similar mechanism.  
 
ICP0 RING-finger dependent degradation of IRF-3.  The ICP0 immediate-early 
protein is an E3 ubiquitin ligase, and many of its functions during infection are attributed 
to this activity (Roizman et al., 2013).  We previously observed that ICP0 expression 
promoted the increased degradation of SeV activated IRF-3, indicating that the ICP0 
RING finger domain might be involved in this phenotype.  This hypothesis was 
supported in this study by the construction of an ICP0 RING finger mutant virus, which    
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Figure 2.8: The RIG-I pathway.  Viral double-stranded RNA is sensed by the RIG-I 
pattern recognition receptor.  Activated RIG-I interacts with mitochondrial associated 
MAVS protein through homotypic interactions between caspase activation and 
recruitment domains (CARDs).  MAVS activates the IRF-3 pathway through TRAF3 and 
subsequently TBK1/IKK&.  The NF-#B pathway is also activated through MAVS via 
TRAF6 ubiquitination of NEMO and degradation of I#β. 
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was unable to promote IRF-3 degradation.  Destabilization of IRF-3 through 
proteasomal degradation is a common immune evasion strategy employed by viruses 
(Viswanathan et al., 2010).  Recently the varicella zoster virus ORF61 protein, an 
ortholog of HSV ICP0, was shown to degrade nuclear IRF-3 in a RING-finger dependent 
manner (Zhu et al., 2011), indicating this phenotype may be broadly active among 
alphaherpesvirus family members. 
Interestingly, ICP0-dependent degradation of activated IRF-3 is not observed in 
human fibroblasts infected with HSV-1(Mossman and Smiley, 2002; Paladino et al., 
2010), nor does it seems to be important for inhibiting IRF-3 activity in this study.  This 
raises the possibility that the degradation of IRF-3 by ICP0 is only observed when 
activated by specific stimuli.  In this study, we have stimulated IRF-3 through the RIG-I 
pathway;  however, IRF-3 activation in response to HSV-1 infection occurs 
independently of RIG-I in fibroblasts (Paladino et al., 2006), although the MDA-5 RIG-I-
like receptor has been implicated in sensing HSV-1 in other cell types (Melchjorsen et 
al., 2010).  Furthermore, It has been noted that SeV, but not HSV-1, induces the 
hyperphosphorylation of IRF-3, which is associated with protein instability (Clement et 
al., 2008; Lin et al., 2004), indicating that while RNA and DNA viruses both activate IRF-
3, distinct signaling pathways may modify IRF-3 differentially.  We therefore hypothesize 
that the hyperphosphorylation of IRF-3 induced by SeV infection allows ICP0 to promote 
its degradation.  
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Mechanism of ICP0-mediated inhibition of IRF-3 responsive gene expression.  
The results of this study indicate that ICP0-mediated degradation of IRF-3 is not 
necessary for the protein to inhibit IRF-3 responsive gene expression.  Instead, our 
results support a model in which ICP0 sequesters IRF-3 away from cellular promoters.  
This may occur by ICP0 directly or indirectly interacting with IRF-3.  In support of this 
hypothesis, we have previously observed that IRF-3 coimmunoprecipitates with ICP0 
during infection, and that the two proteins colocalize by immunofluorescence (Melroe et 
al., 2007).  This potential interaction is further supported by our observation that 
infection with the ICP0 RING finger mutant virus inhibits the cellular turnover of IRF-3.  
We speculate that ICP0 blocks cellular E3 ubiquitin ligases from degrading IRF-3 under 
these conditions, potentially by masking the binding site that is normally recognized by 
these proteins. 
ICP0 interacts with cellular proteins through a variety of mechanisms, some of 
which depend on specific posttranslational modifications of either the target protein or 
ICP0 itself.  For instance, ICP0 contains several SUMO interaction motifs, which allow 
ICP0 to interact with and degrade specific SUMOylated proteins (Boutell et al., 2011). 
Interestingly, IRF-3 has been shown to be SUMOylated upon activation with vesicular 
stomatitis virus (Kubota et al., 2008), which may provide an interaction surface for ICP0 
to bind.  Alternatively, ICP0 interacts with FHA (forkhead associated) domain-containing 
proteins by mimicking a cellular FHA phospho-binding site (Chaurushiya et al., 2012).  
While IRF-3 does not contain a FHA domain per se, the crystal structure of the IRF-3 
IAD (IRF association domain) contains a basic face that structurally resembles the 
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CHK2 FHA domain (Qin et al., 2003).  Further investigation of the ICP0 domains 
necessary for this association will elucidate the mechanism by which ICP0 sequesters 
IRF-3. 
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Abstract 
Innate sensing of microbial components is well documented to occur at many 
cellular sites, including at the cell surface, in the cytosol, and in intracellular vesicles, but 
there is limited evidence of nuclear innate signaling.  In this study we have defined the 
mechanisms of interferon regulatory factor-3 (IRF-3) signaling in primary human 
foreskin fibroblasts (HFF) infected with herpes simplex virus 1 (HSV-1) in the absence 
of viral gene expression.  We found that the interferon inducible protein 16 (IFI16) DNA 
sensor, which is required for induction of IRF-3 signaling in these cells, is nuclear, and 
its localization does not change detectably upon HSV-1 d109 infection and induction of 
IRF-3 signaling.  Consistent with the IFI16 sensor being nuclear, conditions that block 
viral DNA release from incoming capsids inhibit IRF-3 signaling.  An unknown factor 
must be exported from the nucleus to activate IRF-3 through cytoplasmic STING, which 
is required for IRF-3 activation and signaling.  However, when the viral ICP0 protein is 
expressed in the nucleus, it causes the nuclear re-localization and degradation of IFI16, 
which inhibits IRF-3 signaling.  Therefore, HSV-1 infection is sensed in HFF by nuclear 
IFI16 upon release of encapsidated viral DNA into the nucleus, and the viral nuclear 
ICP0 protein can inhibit the process by targeting IFI16 for degradation.  Together these 
results define a pathway for nuclear innate sensing of HSV DNA by IFI16 in infected 
HFF and document the first mechanism by which a virus can block this nuclear innate 
response. 
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Introduction 
Viral infection elicits a number of antiviral innate immune responses, including the 
secretion of type I interferons, interferons α and β (IFNα/β), which act in an autocrine or 
paracrine manner to induce the production of interferon-stimulated genes (ISG) whose 
protein products mediate the antiviral state (Stetson and Medzhitov, 2006).  In addition 
to mediating a localized response, interferon bridges the innate and adaptive immune 
responses to promote immunological memory and clearance of viral infection (Iwasaki 
and Medzhitov, 2010).  
The antiviral response is induced by a set of germ-line encoded pattern 
recognition receptors (PRRs) (Janeway, 1989) that recognize pathogen-specific 
moieties, which include viral genomic DNA and RNA species as well as RNA replication 
intermediates.  These PRRs signal through distinct adaptor molecules but converge on 
the activation of TBK1 (Fitzgerald et al., 2003).  This serine/threonine protein kinase 
phosphorylates the constitutively expressed interferon regulatory factor 3 (IRF-3) 
(McWhirter et al., 2004).  Normally cytoplasmic, phosphorylated IRF-3 translocates to 
the nucleus where it promotes the transcription of ISRE responsive genes, including 
IFN! (Wathelet et al., 1998). 
The host cell is known to distinguish viral and self nucleic acids by sensing both 
chemical and compartmentalization differences between these molecules.  For instance, 
the membrane bound toll-like receptors (TLRs) 3, and 7/8 detect RNA species that 
accumulate in endosomes (Kawai and Akira, 2009).  In addition, resident phagocytic 
cells use these receptors to detect foreign pathogens during immune surveillance of 
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tissues (Schulz et al., 2005).  Chemical differences between self and viral RNAs also 
exist and are detected by a class of cytosolic PRRs known as the RIG-I like receptors 
(RLRs).  The eponymous member of this class, RIG-I, recognizes dsRNA that contains 
5ʼ triphosphates (Hornung et al., 2006), which are unique to RNA virus infection.  MDA5, 
another member of this family, also binds viral dsRNA but potentiates signaling based 
on the length of the RNA species it detects (Kato et al., 2008).  
While recognition of RNA virus infection is well understood, less is known about 
how DNA viruses are sensed by the host cell.  The first DNA sensor identified was 
TLR9, which recognizes unmethylated CpG DNA in endosomal compartments and is 
particularly potent at detecting foreign DNA in plasmacytoid dendritic cells (Ahmad-
Nejad et al., 2002; Latz et al., 2007).  More recently, cytosolic PRRs have been 
identified which sense DNA virus infection in the cytoplasm and include DAI, Pol III, and 
the DEAD/H-box helicase DDX41 (Ablasser et al., 2009; Chiu et al., 2009; Takaoka et 
al., 2007; Zhang et al., 2011).  These sensors are thought to distinguish cellular and 
viral DNA due to compartmentalization differences. 
An interesting paradox in the DNA sensing field involves herpesviruses, which 
constitute a class of large double stranded DNA viruses that replicate in the nucleus of 
infected cells.  While DNA from these viruses is a potent activator of IRF-3, it is unclear 
how they are sensed during infection.  Currently, there is little evidence that nuclear 
DNA sensing can induce a type I interferon response to virus infection.  Recently, IFI16, 
a member of the PYHIN family of proteins was implicated in the type I interferon 
response to herpes simplex virus I (HSV-1) (Unterholzner et al., 2010).  While originally 
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reported to be a cytosolic DNA sensor (Unterholzner et al., 2010), IFI16 is localized in 
the nucleus of many cell types (Veeranki and Choubey, 2012), making it a potential 
candidate for sensing nuclear HSV-1 DNA. 
The importance of the IRF-3 pathway in restricting virus replication has made it a 
target for virus-mediated inhibition.  HSV-1 induces an IRF-3-dependent type I 
interferon/interferon stimulated gene (ISG) response in human fibroblasts in the 
absence of viral gene expression (Everett et al., 2008b; Mossman et al., 2001; Preston 
et al., 2001).  This response is potently inhibited by viral gene expression, suggesting 
that a viral protein inhibits this response.  Like many large DNA viruses, HSV-1 encodes 
multiple mechanisms for inhibiting interferon expression (Melroe et al., 2004).  For 
instance, the late gene product ICP34.5 disrupts phosphorylation of IRF-3 by TBK1, 
while the US11 tegument protein inhibits RIG-I interaction with its downstream adaptor 
MAVS (Verpooten et al., 2009; Xing et al., 2012).  In addition, the immediate-early ICP0 
protein has long been known to inhibit IRF-3 signaling in human fibroblasts;  however, 
the mechanism of its inhibition has not been determined (Eidson et al., 2002).   
Previously, we have shown that ICP0 causes the relocalization of Sendai virus (SeV) 
activated IRF-3 to nuclear foci (Melroe et al., 2007).  This led us to hypothesize that 
ICP0 sequesters IRF-3 from cellular promoters to mediate inhibition of signaling.  
However, because SeV signals through RIG-I, it has remained unclear whether HSV-1 
activated IRF-3 in a similar manner. 
In this study, we investigated the initial activation of IRF-3 signaling in primary 
human fibroblasts in response to HSV-1.  We observed that type I interferon expression 
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in response to replication-defective HSV-1 requires the accumulation of viral DNA in the 
nuclear compartment.  Furthermore, we identified IFI16 as a nuclear sensor of HSV-1 
infection.  In addition, we describe an immune evasion strategy employed by ICP0, 
which inhibits IRF-3 signaling by promoting the degradation of IFI16 during infection.
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Materials and Methods 
Cell culture and viruses. Human foreskin fibroblasts (HFF) were grown in DMEM 
supplemented with 15% fetal bovine serum (FBS).  RAW246.7 macrophage, U2OS, 
Vero, and FO6 cells were maintained in DMEM supplemented with 5% FBS, 5% bovine 
calf serum, and glutamine with appropriate selection media as needed. 
The wild-type HSV-1 KOS strain virus was propagated and titered by plaque 
assay on Vero cells (Knipe and Spang, 1982).  The d106 and d109 viruses were 
propagated on E11 and FO6 cells, respectively, and titered in parallel on FO6 cells 
(Samaniego et al., 1998).  The ICP0-RING finger mutant virus (KOS.RFm) and its 
corresponding rescued virus (KOS.RFr) were propagated and titered on U2OS cells. 
 
Infections. Virus was diluted in cold phosphate-buffered-saline (PBS) containing 0.1% 
glucose and 1% heat-inactivated BCS.  Cells were infected at the stated MOI for 1 h at 
37°C, washed twice with PBS and overlaid with DMEM containing 1% heat inactivated 
BCS.  Infected cells were incubated at 37°C for the indicated length of time. 
 
Drugs. Cells were treated with DMEM containing 5 ng/ml leptomycin B (Sigma-Aldrich) 
for 30 minutes prior to infection.  For proteasome-inhibition studies, cells were treated 
with 1 µM MG132 (Sigma) or .01% DMSO.  TPCK was used at a concentration of 5 
µg/ml.  Drugs were included throughout the adsorption period as well as in overlay 
medium.  
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Cytotoxicity assay.  HFF were cultured in a 96-well plate overnight.   The following day 
cells were treated with control or TPCK-containing media for 6 h.  The viability of the 
cells was determined by assaying their metabolic capacity by the CellTiter-Glo 
Luminescent Cell Viability Assay (Promega) according to the manufacturerʼs 
instructions.  Luminescence was measured by a Spectramax L microplate reader and 
values were normalized to control-treated cells. 
 
Viral DNA analysis by qPCR.  At 2 hours post-infection (hpi) total cellular DNA was 
harvested using a Qiagen Generation Capture Column Kit.  DNA levels of specific 
sequences were determined by quantitative real-time PCR using the Power SYBR 
Green PCR master mix and a Prism 7300 sequence detection system (Applied 
Biosystems).  PCR reactions were carried out in duplicate, and relative copy numbers 
were determined by comparison with standard curves.  Viral DNA was normalized to 
cellular $-actin (human) or GAPDH (mouse) levels.   
 
Cellular RNA analysis by qPCR.  Total RNA was extracted using the Qiagen RNeasy 
Kit and DNase treated using the DNA-free kit (Ambion).  DNase-treated RNA was then 
reverse-transcribed and quantified by real-time PCR (qPCR) as above.  Mock reverse- 
transcribed samples were included as negative controls.  Experiments were conducted 
three times, and the values were averaged.  Samples were normalized to either $-actin 
mRNA or 18S rRNA.  The Student t test was used to determine the statistical 
significance of differences between samples.  
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Nuclear cytoplasmic fractionation.  Nuclear and cytoplasmic extracts were prepared 
with the NE-PER Nuclear and Cytoplasmic Extraction Kit (Thermo Scientific).  The purity 
of nuclear and cytoplasmic extracts was assessed by immunoblotting with anti-lamin 
A/C (cell signaling) and either anti-tubulin or anti-GAPDH antibodies (Abcam), 
respectively. 
 
Western blots.  Cells were lysed in NuPAGE® LDS Sample Buffer, and proteins were 
resolved on NuPAGE® 4-12% Bis Tris Gels (Invitrogen).  Proteins were transferred to 
PVDF membranes, and western blots were developed using Luminate Forte Western 
HRP substrate (Millipore).   
 
Indirect immunofluoresence.  HSV-1 infected HFF grown on coverslips were fixed 
with 2% formaldehyde, permeabilized with 0.5% NP40, and blocked in 5% normal goat 
serum.  Fixed cells were incubated with antibodies for 30 min at 37 °C and washed two 
times with PBS containing 0.05% Tween 20 followed by one wash with PBS.  Alexa 
Fluor 488- and 594-conjugated secondary antibodies were incubated with cells for 2 
hours at 25°C.  The coverslips were washed as above and mounted in ProLong Gold 
antifade reagent (Invitrogen). Images were acquired using an Axioplan 2 microscope 
(Zeiss) with a 63X objective and Hamamatsu CCD camera (model C4742-95).  Images 
were arranged in figures using Adobe Photoshop CS4 (Adobe Systems, Seattle, WA).  
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siRNA transfections.  Double-stranded IFI16-specific, STING-specific and nontarget 
control siRNAs were purchased from Dharmacon.  The pooled siRNA were transfected 
into HFF using the DarmaFECT 2 transfection reagent (Dharmacon) at a final siRNA 
concentration of 5 nM according to the manufacturerʼs instructions.  At 3 days post-
transfection cells were assayed for IFI16 or STING levels by immunoblotting and/or 
infected with HSV-1. 
 
Flow cytometry.  Infected HFF were trypsinized and washed once with ice-cold PBS 
containing 1 mM sodium orthovanadate.  Cells were fixed for 20 minutes with 1.5% 
formaldeyde and incubated in permeabilization buffer (0.2% saponin, 0.5% bovine 
serum albumin, 1 mM sodium orthovanadate, 1 mM beta glycerophosphate, 50 mM 
sodium fluoride) for 15 minutes.  Cells were incubated in permeabilization buffer with 
primary antibody for 1 hour at 25 °C, and then washed and stained with secondary goat 
anti-rabbit fluorescein isothiocyanate (FITC)-conjugated antibody (Jackson 
ImmunoResearch Labs, West Grove, PA) for 1 hour in permeabilization buffer and 
analyzed by flow cytometry.   
 
Antibodies.  Antibodies used in Western blot experiments were mouse anti-IFI16 
(ab55328, 1:1000, Abcam), rabbit anti-phosphoTBK1 (Ser 172) (D52C2, 1:1000, Cell 
Signaling), mouse anti-GAPDH (G041, 1:5000, Applied Biological Materials), rabbit anti-
TMEM173 (ab92650, 1:2000, Abcam), mouse anti-ICP0 (1:1000, EastCoast Bio), rabbit 
anti-Lamin A/C (1:2000, Cell Signaling), mouse anti-!-Tubulin (Clone JDR.3B8, 1:2000, 
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Sigma-Aldrich), rabbit anti-phosphoIRF3 (Ser396) (4D4G, 1:1000, Cell Signaling), and 
rabbit anti-p204 (1:500, (Liu et al., 1999).  HRP-conjugated goat antibodies were used 
at 1:10,000 (Santa Cruz Bio-technology)  
For the Indirect Immunofluorescence studies mouse anti-IFI16 (ab55328, 1:200, 
Abcam), rabbit anti-ICP0 (CLU7, 1:150,(Lium et al., 1996)), and mouse anti-IRF3 (SL-
12, 1:150, Santa Cruz Bio-technology).  Goat anti-mouse Alexa-488 (Jackson 
ImmunoResearch) and anti-rabbit Alexa 594 (Jackson ImmunoResearch) were used at 
1:500 for secondary detection. 
 
Primers. 
 
Name Use Primer Sequence 
hIFN" qRT-PCR 5ʼ-AAACTCATGAGCAGTCTGCA-3ʼ 
5ʼ-AGGAGATCTTCAGTTTCGGAGG-3ʼ 
 
hISG56 qRT-PCR 5ʼ-AAGGCAGGCTGTCCGCTTA-3ʼ 
5ʼ-TCCTGTCCTTCATCCTGAAGCT-3ʼ 
 
hISG54 qRT-PCR 5ʼ-ACGGTATGCTTGGAACGATTG-3ʼ 
5ʼ-AACCCAGAGTGTGGCTGATG-3ʼ 
 
hIL-6 qRT-PCR 5ʼ-ACCGGGAACGAAAGAGAAGC-3ʼ 
5ʼ-CTGGGAGTTCCAGGGCTAAG-3ʼ 
 
h#-actin qRT-PCR 
and qPCR 
5ʼCACCGCCGCATCCTCCTCTTC-3ʼ 
5ʼ-GTGGTGCCGCCCGACAGC-3ʼ 
 
h18s 
RNA 
qRT-PCR 5ʼ-GCATTCGTATTGCGCCGCTA-3ʼ 
5ʼ-AGCTGCCCGGCGGGT-3ʼ 
 
mIFN" qRT-PCR 5ʼ-AGCTCCAAGAAAGGACGAACAT-3ʼ 
5ʼ-GCCCTGTAGGTGAGGTTGATCT-3ʼ 
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mISG56 qRT-PCR 5ʼ-TGGCCGTTTCCTACAGTT-3ʼ 
5ʼ-TCCTCCAAGCAAAGGACTTC-3ʼ 
 
mISG54 qRT-PCR 5ʼ-ATGAAGACGGTGCTGAATACTAGTGA-3ʼ 
5ʼ-TGGTGAGGGCTTTCTTTTTCC-3ʼ 
 
mGAPDH qRT-PCR 5ʼ-CTGACGTGCCGCCTGGAGAAAC-3ʼ 
5ʼ-CCCGGCATCGAAGGTGGAAGAGT-3ʼ 
 
ICP8 qPCR 5′-GCCCGGGCGCTGCTTGTTCTCC-3′ 
5ʼ-CGTCCGCCGTCGCAGCCGTATC-3′  
(Cliffe and Knipe, 2008) 
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Results 
Induction and inhibition of IRF-3 signaling in human fibroblasts.  To investigate the 
mechanisms by which HSV infection induces IFN! expression and how virus encoded 
ICP0 inhibits that process, we defined a system to investigate IRF-3 signaling in human 
foreskin fibroblasts (HFF) infected with the HSV-1 replication-defective d109 and d106 
viruses.  The d109 virus contains mutations in the five immediate-early genes ICP0, 
ICP4, ICP22, ICP27, and ICP47, effectively blocking all viral gene expression during 
infection (Samaniego et al., 1998).  In contrast, the d106 virus expresses ICP0, but no 
additional immediate-early gene products.  Consistent with previous results in human 
embryonic lung cells (Eidson et al., 2002), we found that HFF infected with d109 
showed a MOI-dependent induction of the IRF-3 responsive gene ISG54, while d106 
virus infection resulted in much lower levels of expression of this gene (Figure 3.1A).  
Because HSV-1 mutants that lack ICP0 have been shown to have differing particle to 
pfu ratios (Everett et al., 2004a), we also determined whether cells were exposed to the 
same amount of viral DNA during equal MOI infections with d109 and d106.  This was 
particularly important in light of DNA sensing pathways playing a major role both in 
detecting HSV-1 and inducing IRF-3 signaling during infection (Conrady et al., 2012; 
Unterholzner et al., 2010).  To test this possibility, we used real-time PCR (qPCR) to 
quantify the amount of viral DNA associated with cells during infection.  Interestingly, 
infection with d109 led to 5-fold more viral DNA being associated with cells at 1 hour 
post-infection (hpi) (Figure 3.1B).  When the amount of infectious virus was adjusted, we 
observed similar amounts of viral DNA in cells infected with the d109 and d106 viruses  
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Figure 3.1:  Establishment of an HSV-1 infection system to study IRF-3 signaling. (A) 
Induction of ISG54.  HFF were infected with increasing MOIs of d106 or d109 virus and 
total cellular RNA was harvested at 6hpi.  ISG54 mRNA levels were normalized to #-
actin levels and further normalized to mock-infected samples.  Mean values ± SEM are 
shown.  (B) Viral genome numbers in infected cells.  RAW264.7 cells were infected with 
d106 or d109 at an MOI of 1.  Total cellular DNA was harvested at 2 hpi, and relative 
viral DNA levels were analyzed by qPCR using primers specific for the ICP8 gene.  
Levels were normalized to cellular GAPDH gene levels.  (C) ICP8 gene levels from 
RAW264.7 (Left) or HFF (Right) infected with d106 at an MOI of 5 and 50, or d109 at an 
MOI of 1 and 10.  Mean values ± SEM are shown (n=3). 
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(Figure 3.1C).  These results suggested that d109 has a higher particle-to-pfu ratio than 
d106;  therefore, further experiments were conducted with both equal-PFU and equal-
genome infections.  
To examine the kinetics of IRF-3 responsive gene expression in response to 
HSV-1 infection, we infected cells with d109 (MOI 10) or d106 (MOI 10 and 50), and 
harvested total RNA at 2, 4, and 6 hpi.  The relative levels of IFN", ISG56, and ISG54 
transcripts were measured by qRT-PCR and normalized to #-actin RNA levels.  By 4hpi, 
the d109 virus induced measurable amounts of the responsive genes examined (Figure 
3.2A-C).  In contrast, we observed lower levels of expression of these genes in d106 
virus-infected cells, confirming that ICP0 was sufficient to inhibit IRF-3 signaling.  As a 
control, ICP0 expression had no effect on levels of expression of the NF-#B-dependent 
IL-6 gene (Figure 3.2D).  Similar results for the IRF-3 responsive genes were seen in 
infected RAW246.7 macrophage (Figure 3.3).  These results argued that HSV-1 
infection induces IRF-3 signaling early during infection and expression of ICP0 rapidly 
counteracts this pathway.  Therefore, these results defined a system to study the 
mechanism of activation and inhibition of the IRF-3 pathway. 
 
Conditions that block release of HSV DNA from capsids reduce IFN! and 
ISG induction.  The ability of d109 virus to induce IFN! indicated that HSV-1 infection 
activates IFN! prior to immediate-early gene expression.  Therefore, to define the 
mechanism of induction of IFN", we assessed how d109 activates IRF-3 signaling in  
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Figure 3.2:  HSV-1 induces IRF-3 responsive genes in the absence of viral gene 
expression.  RNA was harvested from HFF infected with d106 (MOI 10 or 50) or d109 
(MOI 10) at 2, 4, and 6 hpi.  RNA levels for (A) IFN", (B) ISG54, (C) ISG56, and (D) IL-6 
were determined by RT-qPCR.  Cellular RNA levels were normalized to #-actin levels 
and further normalized to control 6 hpi values.  Mean values ± SEM are shown (n=4). 
*p<0.05, compared with d106-infected cells (Studentʼs t-test). 
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Figure 3.3: HSV-1 induces IRF-3 responsive genes in RAW264.7 cells the absence of 
viral gene expression.  RNA was harvested from cells infected with d106 (MOI 1 or 5) or 
d109 (MOI 1) at 2 and 4hpi.  RNA levels for (A) IFN", (B) ISG56, and (C) ISG54 were 
determined qRT-PCR.  Cellular RNA levels were normalized to GAPDH and further 
normalized to d109 values at their respective time points.  Mean values ± SEM are 
shown (n=5). *p<0.05, **p<0.01,***p <0.001, compared with d109-infected cells 
(Studentʼs t-test). 
! ()!
HFF.  Upon entry, HSV-1 capsids rapidly translocate to the nuclear periphery where 
they dock at nuclear pores and subsequently release their viral DNA into the nucleus. 
To investigate whether accumulation of viral DNA in the nucleus was required for IRF-3-
responsive gene expression, we examined IFN" expression during infection in the 
presence of tosyl phenylalanyl chloromethyl ketone (TPCK).  This serine/cysteine 
protease inhibitor inhibits cleavage of VP1-2 during infection and blocks viral DNA 
release into the nucleus (Jovasevic et al., 2008).  HFF treated with TPCK or control 
medium were infected with d109 virus or treated with the TLR3 agonist 
polyinosinic:polycytidylic acid (poly I:C), total RNA was harvested at 6hpi and analyzed 
by qRT-PCR.  TPCK treatment virtually eliminated the expression of IFN" and ISG54 in 
response to d109 virus infection compared to control cells (Figure 3.4 A and B) but had 
a less dramatic effect on the induction of ISG54 in response to poly I:C (Figure 3.4C).  
These results argued for a specific effect of TPCK on HSV-induced signaling as 
opposed to poly I:C signaling.  Although cell viability was not affected by TPCK 
treatment at the concentration used (Figure 3.4D, 5µM), TPCK could have additional 
effects on cellular processes, including the chymotrypsin-like activity of the proteasome.  
Therefore, we also treated cells with MG132 to determine the contribution of the 
proteasome in sensing of d109 infection.  Interestingly, MG132 treatment had no effect 
on ISG54 expression, although it did reduce IFN" somewhat (Figure 3.4 A and B).  This 
differential inhibition by MG132 may be explained by differences in transcription factor 
recruitment to the IFN" and ISG54 promoters.  Although recruitment of IRF-3 is 
sufficient to activate the ISG54 promoter, expression of IFN" requires additional  
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Figure 3.4:  Induction of IRF-3 responsive genes requires viral DNA release from 
incoming capsids.  HFF were pretreated with DMSO, TPCK, or MG132 for 30 minutes 
prior to and throughout infection with d109 at an MOI of 10. Cellular RNA was harvested 
at 6hpi and (A) ISG54 and (B) IFN" levels were determined by RT-qPCR.  RNA levels 
were normalized to 18s rRNA followed by normalization to corresponding mock 
treatment values.  (C) HFF were pretreated with DMSO or TPCK for 30 minutes prior to 
and throughout infection with the d109 virus (MOI 10) or treatment with poly I:C (100 
µg/ml).  Cellular RNA was processed as above.  (D) Cell viability assay using CellTiter-
Glo Luminescent reagent.  Cells were treated with increasing amounts of DMSO or 
TPCK and cell viability was analyzed at 6 hours post-treatment.  (E) Western blot 
analysis of pTBK1 and Tubulin levels in drug-treated and d109-infected cells.  Mean 
values ± SEM are shown (n=3). *p<0.05, compared with DMSO-treated cells (Studentʼs 
t-test). 
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transcription factors, including NF-#B whose activation is dependent on proteasomal 
degradation of the I#B inhibitor (Karin and Greten, 2005).  Consistent with TPCK but not 
MG132 blocking IRF-3 responsive gene expression, TPCK reduced TBK1 
phosphorylation at Ser-172 in d109-infected cells, whereas MG132 showed no effect 
(Figure 2.4E).  Phosphorylation of this serine is essential for TBK1 kinase activity and 
thus the activation of IRF-3 (Kishore et al., 2002).  In total, these results argued that the 
IRF-3 signaling response to HSV-1 infection requires the release of capsid-associated 
viral DNA into the nucleus and does not require proteasome activity.  
 
IFI16 is necessary for HSV-1 induced IFN! expression in HFF.  The IFI16 DNA 
sensor and its mouse ortholog p204 have been shown to be necessary for IRF-3 
responsive gene expression in response to HSV-1 infection in THP-1 monocytes, 
RAW264.7 macrophage, and corneal epithelial cells (Conrady et al., 2012; Unterholzner 
et al., 2010).  To test the importance of IFI16 in HSV-1 activation of IRF-3 signaling in 
HFF, we examined IFN" expression during infection in the absence of IFI16.  HFF were 
transfected with control siRNA (siControl) or siRNA targeting IFI16 (siIFI16) for 3 days 
(d), followed by infection with d109 or SeV for 6 h.  Western blot analysis of the resulting 
protein lysates showed robust knockdown of IFI16 in siIFI16-treated cells compared to 
cells treated with control siRNA (Figure 3.5A).  When mRNA expression was examined 
in d109-infected cells by qRT-PCR, there was a marked reduction in IFN" expression in 
siIFI16-treated cells compared to control cells (Figure 3.5C).  In contrast, knockdown of 
IFI16 did not have a significant effect on SeV induced IFN" expression  
! )"!
 
 
 
 
 
 
 
 
 
 
Figure 3.5: IFI16 and STING are required for HSV-1 induced IFN! induction.  HFF were 
treated with control siRNA (siControl) or siRNA targeting IFI16 (siIFI16) or STING 
(siSTING) for 3 d followed by infection with d109 (MOI 10) or SeV (100 HAU/8x10^5 
cells).  Cells were harvested for RNA and protein analysis at 6 hpi.  (A and B) Western 
blot of IFI16, pTBK1, STING, and GAPDH levels in siRNA treated cells.  (C and D) RNA 
samples were analyzed by RT-qPCR.  IFN" RNA levels were normalized to 18s rRNA 
followed by normalization to corresponding mock values.  Mean values ± SEM are 
shown (n=3). 
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(Figure 3.5D), consistent with previous findings (Unterholzner et al., 2010).   
Furthermore, phosphorylation of TBK1 at Ser-172 was diminished in d109-infected IFI16 
knockdown cells relative to cells receiving control siRNA (Figure 3.5A).  Together these 
results were consistent with IFI16 being necessary to activate the IRF-3 signaling 
cascade during HSV-1 infection.  
STING, a cytoplasmic scaffolding protein, is essential for the IFN! response to 
immunostimulatory DNA molecules and HSV-1 infection in mouse embryonic fibroblasts 
(Ishikawa et al., 2009).  In addition, an immunostimulatory VACV 70mer has been 
shown to induce an association between STING and IFI16 in THP-1 cells by co-
immunoprecipitation (Unterholzner et al., 2010).  To determine whether STING was 
required for HSV-1 mediated IFN! response in HFF, we examined IFN" mRNA 
expression in HFF treated with STING siRNA.  At 6 hpi, we observed a marked 
reduction in IFN! expression in the absence of STING in d109-infected cells (Figure 
3.5C).  Treatment with STING siRNA had no significant effect on SeV induced IFN! 
expression (Figure 3.5D).  Interestingly, although STING protein expression was 
reduced only modestly upon treatment with STING siRNA (Figure 3.5B), its loss had a 
greater impact on IFN! expression than IFI16 knockdown in response to d109 infection.  
In addition, we also observed a decrease in STING protein levels in SeV-infected 
siControl- and siSTING-treated HFF, consistent with the previously observed RNF5-
mediated degradation of STING in response to SeV infection (Zhong et al., 2009).   
Together, these results argued that STING is important for the induction of IFN" in 
response to HSV-1 infection and may play a role downstream of IFI16 in HFF. 
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IFI16 is nuclear in uninfected and d109-infected HFF cells.  The subcellular 
localization of IFI16 can be either nuclear or cytoplasmic, depending on the cell type  
[reviewed in (Veeranki and Choubey, 2012)], and it has been reported to be nuclear in 
HFF (Cristea et al., 2010).  We confirmed that IFI16 was nuclear in HFF by 
immunofluorescence (Figure 3.6A).  Nuclear export of IFI16 has been reported during 
infection of endothelial cells with Kaposi sarcoma-associated herpesvirus (KSHV) and 
was associated with an induction of inflammasome and NF-#B signaling (Kerur et al., 
2011).  Interestingly, when we examined IFI16 localization in HFF during infection with 
d109, we did not observe a change in the localization of IFI16;  i.e, IFI16 was nuclear in 
mock- and d109-infected cells (Figure 3.6A).  Similar results were obtained using the 
1G7 IFI16 monoclonal antibody (Santa Cruz) (data not shown), which showed nuclear 
export of IFI16 in a previous study (Kerur et al., 2011).  To confirm this phenotype, we 
examined IFI16 localization by biochemical fractionation.  Nuclear and cytoplasmic 
fractionation was performed on HFF infected with d106 or d109 viruses at 4 hpi.  
Consistent with our immunofluorescence results, IFI16 was completely nuclear in 
uninfected and d109-infected cells (Figure 3.6B).   
STING was localized in the cytoplasm of uninfected cells as shown by 
fractionation, and it showed no change in localization following d109 infection (Figure 
3.6B).  Although in this experiment cells infected with a higher MOI of d106 showed a 
slight increase in nuclear-localized STING (Figure 3.6B), this was not observed in other 
experiments.  The absence of IFI16 in the cytoplasm of d109-infected HFF suggested  
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Figure 3.6: IFI16 is localized in the nucleus during HSV-1 infection.  (A) Fibroblasts 
infected with d109 virus were fixed and stained with an antibody specific for IFI16 
(shown in green) at 4hpi. The white bar represents 5µm.  (B) Nuclear and cytoplasmic 
fractions were prepared from cells infected with d109 and d106, and analyzed by 
immunoblot for ICP0, IFI16, and STING localization.  Tubulin and Lamin A/C represent 
the fractionation efficiency.  (C) Cells were treated with leptomycin B for 30 minutes 
prior to and throughout infection with d109 or SeV for 8 h.  Flow cytometry was then 
used to examine the phosphorylation status of TBK1.  Mean values ± SEM are shown 
(n=4). 
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that IFI16 potentiates signaling from the nucleus to the cytoplasm without major 
changes in its distribution in response to HSV-1.  To test whether nuclear export was 
required for activation of IRF-3 signaling during HSV-1 infection, we examined the 
phosphorylation status of TBK1 by flow cytometry when leptomycin B was used to 
inhibit nuclear export of proteins by the CRM1 pathway.  HFF were treated with 
Leptomycin B for 30 min before to infection with HSV-1 d109 or, to stimulate through 
another sensor, infection with SeV.  Infected cells were fixed and stained at 8 hpi with a 
specific antibody raised against phospho-TBK1 ser172.  Treatment of HFF with 
Leptomycin B decreased the percentage of d109-infected cells that stained positive for 
TBK1 phosphorylation by ~70% (Figure 3.6C).  In contrast, phospho-TBK1 staining was 
only slightly decreased in Leptomycin B-treated, SeV-infected cells compared to control-
treated cells.  These results suggested that signaling in response to HSV-1 infection 
requires CRM1-mediated export of a factor(s). 
 
Nuclear ICP0 inhibits IRF-3 upstream and downstream of activation.  The induction 
of IFN" in response to HSV-1 infection is dependent on the IRF-3 transcription factor 
(Menachery and Leib, 2009; Menachery et al., 2010).  The viral ICP0 protein has been 
implicated in inhibiting the IRF-3 pathway;  however, the mechanism of inhibition has 
remained unclear (Eidson et al., 2002; Melroe et al., 2004).  To determine the stage at 
which IRF-3 activation was inhibited by ICP0, we initially examined IRF-3 localization 
during HSV-1 infection by nuclear/cytoplasmic fractionation.  Nuclear and cytoplasmic 
fractions were prepared from HFF infected with d106 or d109 at 4, 6, and 8 hpi.  The 
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efficiency of fractionation was confirmed by the complete localization of GAPDH in the 
cytoplasmic and lamin A/C in the nuclear fractions (Figure 3.7).  At 4hpi, equal amounts 
of activated IRF-3 (pIRF-3 S396) were seen in the nuclei of cells infected with equal-
genome amounts of d109 (MOI=10) and d106 (MOI=50) (Figure 3.7A, lanes 14,16).  
Cells infected with an equal MOI of d106 (MOI=10) showed delayed IRF-3 
accumulation, most likely due to decreased viral DNA being present during infection 
(Figure 3.7A, lane 15).  Interestingly, by 6hpi pIRF-3 S396 had continued to accumulate 
in the nuclei of cells infected with d109, but was at very reduced levels in cells 
expressing ICP0 (d106).  Additional experiments in RAW264.7 cells revealed a similar 
difference in d109 and d106 infected cells at 2 and 4hpi (Figure 2.7B).  Because 
differences in ISG54 expression were observed in HFF by 4hpi (Figure 2.2B), the 
results taken together suggest that ICP0 is capable of blocking IRF-3 activity at early 
times in the nucleus as well as upstream of IRF-3 activation at later stages of infection. 
Previously, we have shown that ICP0 expression causes the relocalization of 
SeV activated IRF-3 in the nuclei of infected cells (Melroe et al., 2007).  We therefore 
hypothesized that ICP0 sequesters IRF-3 from its normal nuclear activity.  To determine 
whether this sequestration model applied to the situation at 4hpi in infected HFF, we 
examined IRF-3 localization by indirect immunofluorescence.  At 6hpi, we fixed d109- 
and d106-infected HFF and stained them with antibodies specific for IRF-3 and ICP0.  
The IRF-3 antibody used in this experiment (SL-12) preferentially binds to activated IRF-
3 (Melroe et al., 2004);  therefore, we detected diffusely nuclear IRF-3 in d109-infected 
cells (Figure 3.8e).  In contrast, cells infected with d106 showed a relocalization of IRF-3  
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Figure 3.7: ICP0 inhibits nuclear accumulation of activated IRF-3.  HFF (A) or 
RAW264.7 (B) cells were mock-infected or infected with the d109 or d106 viruses.  
Nuclear and cytoplasmic fractions were prepared at 2, 4, 6, and 8 hpi.  Fractions were 
probed using antibodies specific for ICP0, IRF-3 and phospho-IRF-3 (Ser396). 
Fractionation efficiency was determined by localization of GAPDH (cytoplasm) and 
Lamin A/C (nucleus). 
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Figure 3.8: ICP0 sequesters nuclear localized IRF-3.  HFF were infected with d109 or 
d106 viruses for 6 hpi.  Samples were fixed and stained using antibodies specific for 
ICP0 (shown in green) and IRF-3 (shown in red).  White bar represents 5µm. 
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to ICP0 foci (Figure 3.8, i and l).  These results argued that nuclear ICP0 inhibits IFN" 
expression early during infection by sequestering IRF-3 in the nucleus of infected HFF. 
 
Effects of ICP0 expression on IFI16.  In WT HSV-1 infection, ICP0 is localized to the 
nucleus initially but accumulates in the cytoplasm at late time points post-infection 
(Kawaguchi et al., 1997).  This change in localization requires viral DNA replication and 
late gene expression (Lopez et al., 2001).  Our nuclear fractionation and 
immunofluoresence studies argued that ICP0 expressed by d106 is mainly if not entirely 
nuclear (Figure 3.6 and 3.7), consistent with the replication-incompetent nature of the 
d106 virus.   Given the nuclear localization of ICP0 and its apparent effect upstream of 
IRF-3 activation, we tested whether ICP0 expression affects nuclear IFI16.  We infected 
HFF with d106 or d109, prepared protein lysates at 6 hpi, and examined them by 
Western blot analysis.  Notably, cells infected with d106 at both an MOI of 10 and 50 
(lanes 3 and 4) showed a marked reduction in the steady state levels of IFI16 compared 
to d109 virus- (lane 2) or mock-infected (lane 1) cells  (Figure 3.9A).  Interestingly, d106 
infection in RAW264.7 cells also promoted the loss of p204, the murine IFI16 ortholog 
(Figure 3.7B, lanes 15 and 16).  In addition, we examined IFI16 localization in d106- and 
d109-infected cells by immunofluorescence at 2, 4, and 6 hpi.  At 2 hpi, IFI16 partially 
localized with nuclear ICP0 foci and subsequently was lost from cells by 4 and 6 hpi 
(Figure 3.9B).  Together these results suggested that ICP0 expression during HSV-1 
infection promotes the relocalization and subsequent degradation of IFI16.  
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Figure 3.9: ICP0 expression promotes IFI16 relocalization and degradation.  HFF were 
infected with d109, d106, or wt-KOS virus.  (A) Whole cell lysates were harvested at 6 
hpi and probed for ICP0, IFI16, IRF-3, phospho-IRF-3 (Ser396), STING, and GAPDH 
using specific antibodies.  (B) Infected cells were fixed and stained at 2, 4, and 6 hpi for 
IFI16 (shown in green) and ICP0 (shown in red). 
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HSV-1 promotes degradation of IFI16 via an ICP0 RING finger-dependent 
mechanism.  Previous studies have shown that ICP0 promotes the degradation of 
cellular proteins in a proteasome-dependent manner through the E3 ligase activity of its 
RING finger domain (Boutell et al., 2002).  This domain coordinates the ubiquitination of 
specific target proteins and defines ICP0 as an E3 ubiquitin ligase.  To test the 
involvement of the ubiquitin-proteasome pathway in the loss of IFI16, we examined 
IFI16 protein levels in the presence of the proteasome inhibitor MG132.  We treated 
HFF with MG132 or DMSO for 30 minutes before infection with wt HSV-1 KOS strain, 
and drug treatment was continued throughout infection.  At 8 hpi we harvested cell 
lysates and probed for IFI16 expression.  Treatment with MG132 inhibited the loss of 
IFI16 observed during infection (Figure 3.10A).  To test whether loss of IFI16 in our 
system was dependent on RING finger domain activity, we constructed an ICP0 RING 
finger mutant virus by mutational alteration of cysteine residues 116 and 156 to alanine 
and glycine, respectively.  These mutations abolish ICP0 ligase activity by disrupting 
zinc coordination (Lium and Silverstein, 1997; Vanni et al., 2012).  The RING finger 
mutant virus, KOS.RFm, was incapable of degrading USP7 (Boutell et al., 2005) as 
compared to the rescued virus, KOS.RFr, but KOS.RFm ICP0 localized normally in the 
nucleus of infected cells.  We harvested cell lysates from KOS.RFm- or KOS.RFr-
infected cells at 8 hpi and probed for ICP0 expression and IFI16 levels.  We found that 
while KOS.RFm expressed similar levels of ICP0 as compared to KOS.RFr, the virus 
was unable to promote the degradation of IFI16 (Figure 3.10B).  Based on these results  
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Figure 3.10: ICP0 promotes the degradation of IFI16 in a proteasome- and RING 
finger-dependent manner.  (A) HFF were pretreated with DMSO or MG132 for 30 
minutes prior to and throughout infection with wt-HSV (KOS) virus at an MOI of 10.  
Whole cell lysates were harvested at 8 hpi and ICP0.  (B) Cells were infected with the 
ICP0 RING-finger mutant virus (KOS.RFm) and its Rescue (KOS.RFr).  Whole cell 
lysates were harvested and analyzed as in (A).  (C) HeLa cells were transfected with 
indicated plasmids for 24hpi and whole cell lysates were analyzed as in (A). 
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we concluded that ICP0 promotes the degradation of IFI16 in a proteasome- and RING 
finger domain-dependent manner. 
We next examined whether additional domains of ICP0 are necessary for the 
observed degradation of IFI16.  HeLa cells were co-transfected with a Myc-tagged IFI16 
expression plasmid and either wt-ICP0 (pICP0), an ICP0 construct deleted for amino 
acids 1-104 (pd104) or an ICP0 nonsense mutant (pn525) that lacks amino acids 525-
775 (Figure 3.10C).  Both wt-ICP0 and pn525 promoted the degradation of IFI16, 
indicating that while ICP0 expression is sufficient to promote the loss of IFI16 the C-
terminus of ICP0 is not necessary for this activity.  Interestingly, the N-terminus of ICP0 
appeared to be necessary for the degradation of IFI16, as we did not observe a loss of 
IFI16 in pd104-transfected cells.   
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Discussion 
 
 Sensing of microbial macromolecules by innate immune mechanisms has been 
demonstrated to take place at the cell plasma membrane, in internal vesicles, and in the 
cytoplasm, but there has been little clear evidence that innate sensing takes place in the 
cell nucleus.  Furthermore, sensors of viral or bacterial DNA have been considered to 
be cytosolic in origin (Sharma and Fitzgerald, 2011).  In this study, we demonstrate that 
HSV-1 DNA must be delivered to the cell nucleus for sensing by the nuclear IFI16 
sensor and that, although IFI16 appears to remain in the nucleus after viral DNA 
recognition, signaling takes place by export of an unidentified molecule to activate IRF-3 
through STING in the cytoplasm.  The viral ICP0 protein in its nuclear form can re-
localize IFI16 within the nucleus and promote its degradation, thereby blocking further 
signaling.  The observations that viral DNA is delivered to the nucleus, that the sensor is 
nuclear, and that an inhibitor is nuclear strongly support the hypothesis that sensing of 
HSV-1 DNA occurs in the nucleus in human foreskin fibroblasts. 
 
Nuclear Sensing of HSV-1 DNA.  IFI16 has been defined as being involved in IFN! 
and CXCL10 induction in HSV-infected THP-1 cells (Unterholzner et al., 2010) and 
epithelial cells (Conrady et al., 2012), respectively.  Originally described as a cytosolic 
DNA sensor (Unterholzner et al., 2010), IFI16 was recently implicated in sensing Kaposi 
sarcoma-associated herpesvirus (KSHV) in the nucleus of infected cells (Kerur et al., 
2011).  The latter study found that IFI16 colocalized with nuclear KSHV genomes and 
was subsequently translocated to the cytoplasm where it induced inflammasome and 
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NF-#B signaling.  We found that IFI16, which is nuclear in HFF, is involved in the 
induction of an IFN response to HSV-1 in this cell line, because knockdown of IFI16 
decreased IFN" expression during infection with the d109 virus.  Endosomally localized 
TLR9 was the first sensor identified to recognize HSV-1 DNA (Lund et al., 2003);  
however, its expression is restricted to plasmacytoid dendritic cells and B cells in 
humans and thus is unlikely to be a sensor of HSV-1 in HFF.  Indeed, Rasmussen et al 
previously reported that conventional dendritic cells, macrophage and mouse embryonic 
fibroblasts infected with HSV-1 could secrete IFN! in a TLR9-independent but viral 
DNA-dependent manner (Rasmussen et al., 2007).   Additional cytosolic sensors have 
been identified which recognize HSV-1 DNA;  however, it has remained unclear how this 
viral DNA gains access to the cytosolic compartment during infection, given that the 
capsid likely protects viral DNA from cytosolic sensors during transport through the 
cytoplasm.  Some have proposed that viral DNA may be made available to the cytosolic 
compartment by the degradation of viral capsid (Paludan et al., 2011).   Our 
experiments revealed that chemical inhibition of the proteasome in HFF had no effect on 
ISG54 expression in response to HSV-1.   Instead, blocking the release of viral DNA 
into the nucleus of infected cells by TPCK treatment (Jovasevic et al., 2008) greatly 
diminished the cellular response to HSV-1 infection.  These results are consistent with a 
need to deliver the viral DNA to the nucleus for IFN! induction in HFF.  Other cell types, 
however, may have means for freeing viral DNA in the cytoplasm or endosomes so that 
other receptors can initiate innate responses. 
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  The sensing of viral DNA in the nucleus raises the question of how IFI16 
distinguishes between nuclear viral and cellular DNA.  The issue of specificity was one 
of the reasons that the compartmentalized cytosolic and endosomal sensing of DNA 
was attractive.  IFI16 is known to bind to both single- and double-stranded DNA in vitro 
(Unterholzner et al., 2010);  thus, it should be able to bind to cellular or viral DNA.  IFI16 
may bind preferentially to the under-chromatinized HSV DNA, DNA ends, or nicks and 
gaps in HSV DNA.  HSV DNA is known to be rapidly chromatinized upon entry into the 
cell nucleus (Cliffe and Knipe, 2008; Oh and Fraser, 2008) although the histone 
association with HSV DNA is less densely packed (Cliffe and Knipe, 2008) and looser 
(Lacasse and Schang, 2010) than cellular chromatin.  The altered chromatin structure 
may allow IFI16 binding and activation of the signaling pathway.  IFI16 has been 
implicated in the DNA damage response by its interactions with BRCA1 and p53 
(Aglipay et al., 2003; Johnstone et al., 2000).  HSV infection is known to activate DNA 
damage response pathways (Lilley et al., 2005; Shirata et al., 2005; Wilkinson and 
Weller, 2004);  therefore, the free ends of HSV DNA or nicks and gaps could provide 
DNA binding sites for IFI16 to activate the IRF-3 signaling pathway as well as potentially 
other signaling cascades.  Currently there are conflicting reports as to whether DNA 
damage itself induces IFN-! expression.  A recent study in primary human monocytes 
suggested that IFN-" and -$, but not -!, were induced in response to the DNA damaging 
agent etopiside (Brzostek-Racine et al., 2011).  However, additional reports have shown 
that treatment of young human diploid fibroblasts with bleomycin caused an increase in 
the expression of IFI16 (Duan et al., 2011), and irradiation of bone marrow-derived 
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mouse macrophages increased ISG expression in an IFN!-dependent manner (Mboko 
et al., 2012).  Interestingly, no detectable double-stranded break (DSB) response has 
been detected in UV-inactivated HSV-1 infected cells (Shirata et al., 2005), which would 
presumably mimic d109 infection in our system.  However, current methods of detecting 
DSB may be insufficient to detect an initial DNA damage response from nonreplicating 
viral DNA.  Therefore, further studies are needed to understand the relationship 
between IFI16 sensing of viral DNA and the DNA damage response. 
 As we were submitting this manuscript, Li et al reported results showing that 
IFI16 must be nuclear to sense HSV-1 infection (Li et al., 2012).  In this study, the 
authors showed that a HEK293 cell line expressing IFI16 that lacked a functional 
nuclear localization signal was unable to induce IFN" expression in response to HSV-1 
compared to WT-IFI16 expressing cells.  Our results are consistent with and 
complementary to their results and expand on the mechanisms of activation and 
inhibition of IFI16 sensing of HSV-1 infection. 
 
Role for nuclear IFI16 in HSV-1 induced interferon expression.  It is currently 
unclear how nuclear IFI16 induces the cytoplasmic IRF-3 signaling cascade in HFF.  
Previously, cytosolic IFI16 was shown to associate with STING upon activation with 
immunostimulatory DNA (Unterholzner et al., 2010).  In our system, STING knockdown 
reduced the expression of IFN in response to HSV-1 infection, suggesting the 
involvement of this protein in the activation of IRF-3 signaling in HFF.  However, we do 
not observe a measurable relocalization of IFI16 from the nucleus to the cytoplasm 
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during infection.  Additional experiments using the CRM1 inhibitor leptomycin B 
revealed that a nuclear export event is required for the autophosphorylation of the TBK1 
kinase, arguing that additional factors may translocate to the cytoplasm to initiate 
signaling upon IFI16 activation.  The factor(s) that link nuclear IFI16 to cytosolic STING 
are currently unknown and represent a high priority for future studies.  
 
Inhibition of IRF-3 signaling by nuclear ICP0.   In this study we found that HSV ICP0 
can inhibit the IRF-3 pathway through degradation of IFI16.  HSV-1 infection has long 
been known to antagonize the IRF-3 signaling pathway, and the expression of ICP0 
plays a major role in inhibiting this cellular response (Eidson et al., 2002; Melroe et al., 
2004; Melroe et al., 2007).   Our previous studies have shown that ICP0 can block RIG-I 
induced IRF-3 signaling in Sendai virus infected cells by sequestering nuclear IRF-3 and 
reducing its levels (Melroe et al., 2004; Melroe et al., 2007).  In this study we have 
examined the mechanisms of ICP0 inhibition of IRF-3 activation in HSV-infected cells.  
In HFF and RAW246.7 macrophages, we observed that ICP0 inhibits the IRF-3 
signaling pathway at two distinct steps.  Nuclear/cytoplasmic fractionation and analysis 
of IFN! and ISG expression revealed that ICP0 initially inhibits type I IFN expression at 
a stage after nuclear accumulation of phosphorylated IRF-3.  This early inhibition is 
associated with a relocalization of IRF-3 to ICP0 nuclear foci and is consistent with the 
sequestration of IRF-3 in the SeV co-infection system.  At later times after infection 
ICP0 inhibits the accumulation of IRF-3 in the nucleus coincident with the loss of IFI16.  
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ICP0 is an E3 ubiquitin ligase and promotes the degradation of cellular proteins 
to enhance virus replication and inhibit host innate responses (Boutell et al., 2002; Cai 
et al., 1993).  Others have observed that the ability of ICP0 to inhibit IRF-3 signaling is 
at least partially dependent on functional proteasomes (Eidson et al., 2002; Paladino et 
al., 2010);  however, no cellular target for degradation has been identified.  In addition to 
sequestering IRF-3 in the nucleus, we observed that ICP0 promotes the degradation of 
the IFI16 DNA sensor in a proteasome- and RING finger-dependent manner.  ICP0 is 
associated with the degradation of a number of cellular proteins, but only a limited 
number of these have been shown to directly interact with ICP0 and/or be directly 
ubiquitinated in a reaction involving ICP0 [reviewed in (Roizman et al., 2013)].  
Therefore, it will be important to determine the mechanism by which ICP0 promotes 
degradation of IFI16.  Most importantly, this study provides a mechanism by which a 
virus can inhibit nuclear IFI16 from activating IRF-3 signaling. 
ICP0 may also inhibit IRF-3 signaling in the cytoplasm.  At early times post-
infection ICP0 is localized to the nucleus, whereas upon viral DNA replication the 
protein accumulates in the cytoplasm.  A recent study showed that an ICP0 mutant 
protein without a NLS could inhibit signaling in human embryonic lung fibroblasts 
(Paladino et al., 2010).  It is conceivable that ICP0 can affect IRF-3 activation in the 
cytoplasm when it accumulates there.  Our results do not rule out additional effects of 
ICP0 in the cytoplasm of infected cells;  however, our results argue strongly for the 
ability of nuclear localized ICP0 to inhibit IRF-3 signaling early during infection. 
 
! "++!
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.11: Model of nuclear HSV-1 DNA sensing and inhibition by ICP0. HSV-1 
fusion at the plasma membrane or via endosomal compartments deposits viral capsids 
in the cytoplasm.  Capsids traffic to nuclear pores where viral DNA is released into the 
nucleus.  Nuclear IFI16 senses accumulating viral DNA inducing a nuclear-to-
cytoplasmic signaling cascade activating IRF-3, which dimerizes and translocates to the 
nucleus.  Immediate-early expression of ICP0 sequesters IRF-3 from cellular promoters 
and promotes degradation of IFI16 to inhibit IFN! expression. 
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Based on the studies described here, we propose the following model for the 
activation and ICP0-mediated inhibition of type I interferon expression during HSV-1 
infection (Figure 3.11).  In HFF, HSV-1 infection is sensed initially by IFI16 upon the 
release of viral DNA into the nucleus.  A nuclear-to-cytoplasmic signaling cascade is 
initiated that activates IRF-3 and induces its accumulation in the nucleus.  ICP0 
expressed at early times during infection sequesters this nuclear IRF-3 from cellular 
promoters and blocks type I IFN expression.  In addition, ICP0 targets IFI16 for 
degradation, inhibiting additional signaling and activation of IRF-3.  Determination of the 
mechanism of specific detection of viral DNA in the nucleus within the same cellular 
compartment as cellular DNA will likely shed light on basic cellular mechanisms for 
detection of “foreign” or altered DNA within the cell.  HSV DNA activates DNA damage 
response pathways, and IFI16 has been implicated in the DNA damage response;  thus, 
these results raise the possibility that the IFN response to viral DNA and the DNA 
damage response pathways share sensing or signaling components. 
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Chapter Four: Interferon inducible protein 16 acts as an intrinsic resistance 
factor to silence HSV-1 and transfected DNA gene expression 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
! "+$!
Abstract 
 
 
The intrinsic cellular resistance to infection by large DNA viruses involves the 
silencing of viral DNA in the nucleus.  During herpes simplex virus 1 (HSV-1) infection 
the ICP0 immediate-early protein counteracts this cellular response in part by disrupting 
ND10 bodies.  However, ND10 components do not account for the total restriction 
observed in the absence of ICP0, suggesting that additional unidentified mechanisms 
contribute to silencing the viral genome.  In this study we identify the nuclear IFI16 DNA 
sensor as an intrinsic factor involved in repression of foreign DNA.  Knockdown of IFI16 
enhanced the replication and immediate-early gene expression of an ICP0-null virus.  
This phenotype was independent of downstream STING signaling, and knockdown of 
IFI16 did not affect ND10 accumulation at viral genomes.  Furthermore, overexpression 
of exogenous IFI16 in the permissive U2OS cell line restricted ICP0-null virus gene 
expression.  The repressive activity of IFI16 was not limited to viral DNA as the 
expression of transfected DNA was also inhibited by IFI16.  Together these results 
argue that in addition to its involvement as an innate pattern recognition receptor, IFI16 
mediates an intrinsic immune response to foreign DNA by silencing its expression.   
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Introduction 
 
Classically, the host mechanisms blocking viral infection have been divided into 
two distinct arms of host immunity: the innate and adaptive immune responses. 
However, a third aspect of host immunity has recently been described and termed 
intrinsic immunity or intrinsic antiviral resistance (Bieniasz, 2004).  One major difference 
between these three host responses is the constitutive expression of resistance 
mechanisms.  Both innate and intrinsic immunity act at the primary site of infection and 
mediate an initial cell-based immune response.  However, while innate immunity 
requires de novo cellular gene expression to mediate its antiviral effects (e.g., induction 
of type I interferons), intrinsic resistance acts immediately to counteract viral infection 
through constitutively expressed proteins, known as intrinsic resistance factors.  These 
two cell-based responses are closely linked, however, as many resistance factors are 
upregulated by type I interferons induced by the innate immune response. 
The first intrinsic resistance factors to be characterized were identified as 
mediators of antiretroviral resistance.  For instance, TRIM5" inhibits retroviral infection 
by modulating the capsid uncoating process (Wolf and Goff, 2008), while APOBEC3G is 
incorporated into newly synthesized retrovirus capsids and induces the hypermutation of 
reverse transcribing RNA (Bieniasz, 2004).  In addition, tetherin/Bst-2 inhibits viral 
release by tethering viral particles to the cell surface (Perez-Caballero et al., 2009).  The 
mechanisms employed by these retroviral restriction factors are closely linked to the 
lifecycle of the viruses they target, and as such are thought to have developed during a 
long-term co-evolution of these viruses with their respective hosts (Duggal and 
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Emerman, 2012).  Interestingly, members of the Herpesviridae family, including herpes 
simplex viruses (HSV), have also co-evolved with their hosts, indicated by their high 
seroprevalence but modest pathogenicity.  However, compared to antiretroviral intrinsic 
resistance, little is known about intrinsic resistance factors that target these large DNA 
viruses.  
The most well characterized intrinsic immune response to herpesvirus infection 
involves the action of promyelocytic leukemia protein nuclear bodies (PML NB), also 
known as nuclear domain 10 (ND10) bodies.  These dynamic subnuclear domains are 
made up of a variety of cellular proteins, and have been implicated in several cellular 
responses, including gene expression, DNA damage, apoptosis, and aging (Lallemand-
Breitenbach and de The, 2010).  During HSV-1 infection, ND10 components accumulate 
de novo in the nucleus at sites near incoming viral DNA, and this is associated with their 
ability to restrict viral gene expression (Everett and Murray, 2005).  HSV-1 overcomes 
this restriction through expression of the viral ICP0 immediate-early protein, an E3 
ubiquitin ligase that disrupts ND10 by promoting degradation of the associated PML and 
Sp100 proteins (Chelbi-Alix and de The, 1999; Everett et al., 1998; Muller and Dejean, 
1999).  The importance of counteracting this intrinsic response is documented by 
reports that ICP0-null viruses are significantly attenuated for viral replication, particularly 
in primary human fibroblasts (Everett et al., 2004a; Stow and Stow, 1986).  However, 
depletion of ND10 by simultaneous knockdown of the three major ND10 components, 
PML, Sp100 and hDAXX does not completely rescue the replication of an ICP0-null 
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virus, indicating additional mechanisms are involved in the intrinsic resistance to HSV-
1(Glass and Everett, 2012). 
Recently it was reported that the interferon-inducible protein 16 (IFI16) DNA 
sensor restricts human cytomegalovirus (HCMV) replication in human fibroblasts 
(Gariano et al., 2012).  While IFI16 is known to promote IRF-3 signaling in response to 
herpesvirus infection (Unterholzner et al., 2010), the reported IFI16-dependent 
restriction of HCMV was independent of IFN!, indicating IFI16 may act as an intrinsic 
resistance factor in addition to categorization as an innate pattern recognition receptor.  
Furthermore, our recent identification of IFI16 as a target of ICP0-mediated degradation 
(Orzalli et al., 2012) prompted us to evaluate IFI16ʼs activity as an intrinsic resistance 
factor to HSV infection.  Here we report that IFI16 restricts HSV-1 replication in the 
absence of ICP0 and this phenotype is independent of STING and ND10-mediated 
intrinsic resistance.  In addition, overexpression of a functional IFI16 in permissive 
U2OS cells confers resistance to an ICP0-null virus.  Furthermore, we determined that 
IFI16 acts by silencing the expression of both viral and transfected DNA. 
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Materials and Methods 
Cell culture and viruses.  Human foreskin fibroblasts (HFF) and U2OS cells were 
obtained from American Type Culture Collection (ATCC).  HFF were grown in DMEM 
supplemented with 15% heat-inactivated fetal bovine serum (FBS), 2mM L- glutamine, 
streptomycin, and penicillin (15% DMEM).  U2OS cells were grown in DMEM 
supplemented with 5% heat-inactivated FBS and 5% heat-inactivated bovine calf serum 
(BCS).   The ICP0-null (7134) and rescued 7134R viruses were grown and titred in 
parallel on U2OS cells (Cai and Schaffer, 1989). 
 
Virus infections. Virus was diluted in cold phosphate-buffered-saline (PBS) containing 
0.1% glucose and 1% heat-inactivated BCS.  Cells were infected at the stated MOI for 1 
h at 37°C, washed twice with PBS and overlaid with DMEM containing 1% heat-
inactivated BCS.  Infected cells were incubated at 37°C for the indicated length of time. 
 
siRNA transfections.  Double-stranded IFI16-specific, STING-specific and nontarget 
control siRNAs were purchased from Dharmacon.  The pooled siRNA were transfected 
into HFF using the DarmaFECT 2 transfection reagent (Dharmacon) at a final siRNA 
concentration of 5 nM according to the manufacturerʼs instructions.  The siRNA 
containing media was replaced 24 hours post-transfection, and cells were assayed for 
IFI16 or STING levels by immunoblotting and/or infected with HSV-1 at 72 hours post-
transfection (hpt). 
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Plasmids and DNA transfection. The N-Myc IFI16 plasmid and empty vector 
backbone were kindly provided by S. Conwell (Conwell and Knipe, unpublished data).  
U2OS cells were plated at a density to ensure 50% confluency on the day of 
transfection.  Cells were transfected with 0.5 µg of empty vector or N-Myc IFI16 plasmid 
using the Effectene transfection reagent (Qiagen) and were infected with the indicated 
viruses at 48 hpt. 
HFF were transfected with either 0.5 µg of an empty vector plasmid, pEGFP-C1 
(Clonetech), or pEF1-GFP (provided by C. Cepko, Harvard Medical School) using the 
Lipofectamine LTX reagent (Invitrogen) at 48 hours post-siRNA treatment.  Transfection 
media was replaced at 6 hpt with 15% DMEM and whole cell lysates were harvested 
and processed for flow cytometry or western blot at 36 hpt.  
    
Cellular RNA analysis by qPCR.  Total RNA was extracted using the Qiagen RNeasy 
Kit and DNase treated using the DNA-free kit (Ambion).  Equal amounts of DNase-
treated RNA was then reverse-transcribed and quantified by real-time PCR (qPCR) 
using the Power SYBR Green PCR master mix and a Prism 7300 sequence detection 
system (Applied Biosystems).  PCR reactions were carried out in duplicate, and relative 
copy numbers were determined by comparison with standard curves.  Mock reverse-
transcribed samples were included as negative controls.  Transcript levels were 
normalized to 18S rRNA and made relative to mock-infected samples.  Experiments 
were conducted three times, and the values were averaged.  
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Western blots.  Cells were lysed in NuPAGE® LDS Sample Buffer, and proteins were 
resolved on NuPAGE® 4-12% Bis Tris Gels (Invitrogen).  Proteins were transferred 
overnight to PVDF membranes and blocked with 5% milk in PBS.  Membranes were 
probed with primary antibody at 4°C, washed with PBS containing 0.05% Tween 20 and 
incubated in secondary antibody for 1 h at room temperature.  Western blots were 
developed using Luminate Forte Western HRP substrate (Millipore).   
 
Indirect immunofluorescence.  HSV-1 infected HFF grown on coverslips were fixed 
with 2% formaldehyde, permeabilized with 0.5% NP40, and blocked in 5% normal goat 
serum.  Fixed cells were incubated with antibodies for 30 min at 37 °C and washed two 
times with PBS containing 0.05% Tween 20 followed by one wash with PBS.  Alexa 
Fluor 488- and 594-conjugated secondary antibodies were incubated with cells for 2 h at 
25°C.  The coverslips were washed as above and mounted in ProLong Gold antifade 
reagent (Invitrogen).  Images were acquired using an Axioplan 2 microscope (Zeiss) 
with a 63X objective and Hamamatsu CCD camera (model C4742-95).  Images were 
arranged in figures using Adobe Photoshop CS4 (Adobe Systems, Seattle, WA).   
 
Flow cytometry.  Transfected HFF were trypsinized, pelleted and resuspended in 500 
µl Accumax cell counting solution (Millipore).  Cell suspensions were passed through a 
40 µm filter to prevent clumping and stained with a 1:500 dilution of propidium iodine 
(PI).  Fluorescence readings were collected for 20,000 cells.  PI positive cells were 
gated out during analysis and GFP+ cells were defined on empty vector transfected 
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cells.  Data analysis was performed using FlowJo (Version 9) and graphs were 
constructed using GraphPad Prism software. 
 
Antibodies.  Antibodies used in Western blot experiments were mouse anti-IFI16 
(ab55328, 1:1000, Abcam), mouse anti-GAPDH (G041, 1:5000, Applied Biological 
Materials), rabbit anti-TMEM173 (ab92650, 1:2000, Abcam), mouse anti-ICP0 (1:1000, 
EastCoast Bio), mouse anti-!-Tubulin (Clone JDR.3B8, 1:2000, Sigma-Aldrich), mouse 
anti-IFIT2 (1:1000, ABCAM), and mouse anti-Myc (9E10, 1:2000, Santa Cruz Bio-
technology).  HRP-conjugated goat antibodies were used at 1:5,000-1:20,000 (Santa 
Cruz Bio-technology). 
Antibodies used for indirect immunofluorescence studies were mouse anti-IFI16 
(ab55328, 1:200, Abcam), rabbit anti-ICP8 (3-83, 1:500, (Knipe et al., 1987)), rabbit 
anti-PML (1:1000, Santa Cruz Bio-technology) and mouse anti-ICP4 (39S, 1:200,  
(Showalter et al., 1981). Goat anti-mouse Alexa-488 (Jackson ImmunoResearch) and 
anti-rabbit Alexa 594 (Jackson ImmunoResearch) were used at 1:500 for secondary 
detection. 
Primers. 
 
Name Use Primer Sequence 
hIFN" qRT-PCR 5ʼ-AAACTCATGAGCAGTCTGCA-3ʼ 
5ʼ-AGGAGATCTTCAGTTTCGGAGG-3ʼ 
h18s RNA qRT-PCR 5ʼ-GCATTCGTATTGCGCCGCTA-3ʼ 
5ʼ-AGCTGCCCGGCGGGT-3ʼ 
IFI16 qRT-PCR 5ʼ-ACTGAGTACAACAAAGCCATTTGA-3ʼ 
5ʼ-TTGTGACATTGTCCTGTCCCCAC-3ʼ 
STING qRT-PCR 5ʼ-CCTGAGCAGAACAACTGC-3ʼ 
5ʼ-GGTCTTCAAGCTGCCCACAGT-3ʼ 
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Results 
Reduction of IFI16 enhances ICP0-null virus replication in normal human foreskin 
fibroblasts.  To determine whether IFI16 plays a role in the reduced replication of ICP0- 
null viruses, we treated normal human foreskin fibroblasts (HFF) with siRNA to reduce 
IFI16 expression.  HFF cells were transfected with siRNA specific for IFI16 (siRNA 
IFI16) or nontargeting control siRNA  (siRNA ctrl).  We observed a significant decrease 
in the expression of IFI16 at both the mRNA and protein level at 72 hours post-
transfection (hpt) (Figure 4.1A) and knockdown was robust through 120 hpt. (results not 
shown).  siRNA-treated cells were subsequently infected with an ICP0-null virus (7134) 
or its corresponding rescue (7134R) at a low MOI (0.1), and virus yields were 
determined by plaque assay.  At 48 hpi we observed a ~4 log defect in 7134 virus 
replication compared to 7134R in control-treated cells (Figure 4.1C), consistent with 
previously published reports (Everett and Murray, 2005).  Interestingly, while we 
observed a minimal increase in 7134R virus yield in IFI16 siRNA-treated cells, 
replication of the 7134 virus was significantly increased (seven-fold) in the absence of 
IFI16.  These results suggest that IFI16 restricts HSV-1 replication in the absence of 
ICP0 and that the IFI16 protein likely accounts for a portion of the attenuated ICP0-null 
phenotype seen in human fibroblasts.   
Fibroblasts infected with ICP0-null viruses show enhanced expression of type I 
interferons and interferon-stimulated genes (ISGs) compared to wild-type viruses 
(Paladino et al., 2010) (Figure 4.1D).  The induction of these antiviral genes are, at least  
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Figure 4.1: IFI16 negatively regulates the replication of an ICP0-null virus.  (A) 
IFI16 and (B) STING transcript and protein levels were decreased following transfection 
of HFF with either nontarget control, IFI16-specific, or STING-specific siRNAs.  (C) IFI16 
knockdown resulted in an increase in ICP0-null virus replication relative to cells 
transfected with control siRNAs.  siRNA-transfected cells were infected with HSV-1 
ICP0-null (7134) or a rescue virus (7134R) at an MOI of 0.1, harvested at 48hpi, and 
virus yield was determined by plaque assay on U2OS cells. (D) IFI16 or STING 
knockdown decreased IFN" transcript levels in response to ICP0-null virus infection.  
siRNA-transfected cells were infected with HSV-1 ICP0-null virus at an MOI of 10, and 
RNA was harvested at 6 hpi.  Results are an average of three-(A and B), four-(C) or 
two-(D) independent experiments, and error bars represent the standard error of means. 
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in part, due to nuclear sensing of viral DNA by IFI16 (Orzalli et al., 2012).  Therefore, it 
was possible that the increased replication of 7134 observed in our virus yield assay 
was due to the down regulation of IFI16-induced antiviral genes  (Figure 4.1D).  In a 
study by Everett et al (Everett et al., 2008b), a reduction in IRF-3 or STAT-1 protein 
levels enhanced wild-type and ICP0-null virus replication equally, suggesting that 
antiviral gene expression was not involved in restricting ICP0-null virus replication.  
However, in the aforementioned study, IRF-3 and STAT-1 protein levels were reduced 
by lentivirus vector expression of the parainfluenza protein 5 “V” protein or the NPro 
protein of bovine viral diarrhea virus, which downregulate these signaling pathways, 
respectively (Didcock et al., 1999; Hilton et al., 2006).  In many cases, viral proteins are 
multifunctional and it is unclear whether these proteins could affect additional cellular 
pathways or HSV-1 replication.  We therefore examined the involvement of these 
pathways in ICP0-null virus replication by examining virus yields in the absence of 
stimulator of interferon genes (STING).  This protein is an adaptor in intracellular DNA 
sensing and decreased expression of STING greatly inhibits IRF-3 activation and type I 
interferon induction in response to HSV (Ishikawa and Barber, 2008; Ishikawa et al., 
2009).  In our system, knockdown of STING (Figure 4.1B) increased the replication of 
7134 and 7134R by 1.8 and 2.2 fold (Figure 4.1D), respectively, confirming that 
signaling events downstream of STING, including the induction of type I interferons and 
ISGs, are not involved in the intrinsic resistance to ICP0-null viruses.  Together these 
results indicated that IFI16 acts to restrict viral gene expression independently of STING 
and its role in IRF-3 signaling. 
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Knockdown of IFI16 enhances HSV-1 immediate-early gene expression.  The 
experiments above showed that IFI16 can restrict ICP0-null virus replication and spread; 
however, it was unclear what stage in the viral lifecycle is inhibited by IFI16.  To 
investigate the mechanism(s) of IFI16-mediated inhibition of viral replication we 
examined the expression of the viral ICP4 immediate-early gene during infection of 
siRNA-treated cells.  HFF cells were transfected with IFI16 siRNA or non-target control 
siRNA, infected with 7134 or 7134R at an MOI of 10, and whole cell lysates were 
harvested at 6 or 24 hpi.  Western blot analysis revealed an increase in the expression 
of ICP4 in 7134-infected IFI16 knockdown cells (Figure 4.2), compared to control-
treated cells at both time points, consistent with the increase in viral replication 
observed in Figure 4.1C.  Furthermore, we did not observe an increase in ICP4 
expression during infection with 7134R, consistent with ICP0 overcoming IFI16-
mediated inhibition by promoting the proteasomal degradation of IFI16.  Together these 
results argue that IFI16 inhibits HSV-1 replication early during infection at the stage of 
immediate-early gene expression. 
 
Knockdown of IFI16 enhances plasmid DNA expression.  We next asked whether 
this repressive effect of IFI16 was also exerted on transfected DNA by testing whether 
IFI16 could restrict gene expression from plasmid DNA.  HFF were treated with IFI16 or 
control siRNA and transfected with a GFP construct under the control of a CMV 
promoter (pCMV GFP) at 48 hours post-siRNA treatment.  Whole cell lysates were 
harvested at 24 hpt and GFP protein levels were examined by western blot.  We  
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Figure 4.2: Reducing IFI16 protein levels increases the expression of a viral 
immediate-early protein. Immunoblots examining the levels of the HSV-1 ICP4 
immediate early protein in HFF cells treated with IFI16 or non-targeting control siRNA. 
Treated cells were either mock-infected or infected with an ICP0-null (7134) or rescued 
virus (7134R) at an MOI of 10.  Total whole cell lysates were harvested and probed at 
(A) 6 and (B) 24 hpi. The cellular tubulin gene was used as a recovery and loading 
control. 
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observed an increase in GFP expression in siIFI16 treated cells compared to control 
cells (Figure 4.3A).  This increase was quantified by measuring GFP by flow cytometry 
and we observed a three-fold increase in GFP+ cells in the absence of IFI16 (Figure 
4.3B).  
To determine whether this response was specific to the viral CMV promoter used 
to express the GFP plasmid above, we also examined GFP expression from a plasmid 
under the control of the endogenous elongation factor 1 (EF1) promoter.  While the 
efficiency of transfection was lower in control cells transfected with pEF1 GFP 
compared to pCMV GFP transfected cells, we observed a similar increase in GFP+ cells 
in the absence of IFI16 (Figure 4.3B).  Together these results suggest that IFI16 inhibits 
foreign DNA expression regardless of whether the DNA is introduced to cells by 
infection or transfection and is not specific to DNA that contains viral promoter elements. 
 
Overexpression of IFI16 in a permissive cell line reduces ICP0-null virus gene 
expression.  HSV-1 mutants deficient in functional ICP0 are grown on the 
osteosarcoma U2OS cell line due to an intrinsic ability of these cells to complement 
ICP0-null viruses.  Due to our observation that IFI16 restricts HSV-1 gene expression in 
HFF, we examined whether IFI16 is present and/or functional in U2OS cells.  We 
observed that IFI16 could be detected by western blot in U2OS cells (Figure 4.4A, lane 
1);  however, in contrast to our observations in HFF, infection with 7134R virus at an 
MOI of 10 did not result in the degradation of IFI16 in these cells (Figure 4.4A, lane 3). 
Interestingly, we also observed an inability of ICP0 to degrade IFI16 in additional  
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Figure 4.3: IFI16 restricts plasmid DNA expression in a promoter-independent 
manner.  (A) Immunoblot examining GFP and IFI16 expression in pCMV GFP 
transfected HFF treated with non-targeting control or IFI16 siRNA.  The cellular tubulin 
gene was used as a recovery and loading control.  (B) Quantification of GFP+ cells in 
the presence or absence of IFI16 by flow cytometry.  HFF were transfected with an 
empty vector plasmid or pCMV GFP or pEF1 GFP at 48 hours post siRNA treatment.  
The results are represented as a % of the GFP signal from empty vector transfected 
cells and are an average of two-independent experiments. 
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cell lines, including HeLa and Hep2 cells (results not shown).  Nevertheless, exogenous 
IFI16 introduced to U2OS cells by transfection was degraded during infection with the 
7134R virus (Figure 4.4A, lane 6), suggesting that endogenous IFI16 in U2OS cells may 
be mutated or modified in some way that prevents ICP0 from promoting its degradation.   
The ability of ICP0 to target exogenous IFI16 in U2OS cells indicated the protein might 
be capable of restricting ICP0-null virus gene expression.  In Figure 4.4A we observed 
no difference in the steady-state levels of ICP4 during infection with 7134 in the 
absence or presence of N-Myc IFI16 (lane 2 vs lane 5).  However, this experiment was 
performed at an MOI of 10 to maximize our ability to detect ICP0-dependent 
degradation of IFI16.  Defects in ICP0-null virus gene expression are more apparent at 
low MOI, so we examined the expression of ICP4 during infection at an MOI of 0.1.  
U2OS cells were transfected with an empty vector plasmid or N-Myc IFI16 for 48 h, 
infected with 7134 and 7134R, and whole cell lysates were harvested at 4 hpi.  In 
contrast to our results at a high MOI of infection, expression of N-Myc IFI16 was 
associated with a decrease in ICP4 expression in low MOI 7134-infected cells 
compared to the empty vector control (Figure 4.4B, lane 2 vs lane 5).  Consistent with 
its specificity for ICP0-null viruses, we did not observe a decrease ICP4 expression in 
the presence of N-Myc IFI16 during infection with 7134R (Figure 4.4B, lane 3 vs lane 6).  
Together these results provide further evidence of IFI16ʼs activity as an intrinsic 
resistance factor to ICP0-null virus infection.  Furthermore, our results suggest that 
endogenous IFI16 in U2OS cells is non-functional and accounts for at least a portion of 
this cell lines apparent permissivity to ICP0-null virus replication. 
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Figure 4.4: The effect of IFI16 overexpression on U2OS cell permissivity.  
Expression of exogenous IFI16 resulted in the decreased expression the viral ICP4 
immediate-early gene.  U2OS cells were transfected with either an empty vector control 
or an N-terminally Myc-tagged IFI16 construct.  At 48 hpt, cells were infected with an 
ICP0-null (7134) or rescued virus (7134R) at an MOI of (A) 10, or (B) 0.1.  Whole cell 
lysates were harvested and subjected to Western blot analysis for ICP4, Myc, and IFI16 
protein levels at 4 hpi.  The cellular tubulin gene was used as a recovery and loading 
control.    
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IFI16 relocalizes to sites of HSV-1 viral DNA synthesis.  In an earlier study we did 
not observe a detectable intranuclear relocalization of IFI16 during infection with a 
replication-defective HSV-1 recombinant virus (Orzalli et al., 2012).  However, others 
have reported that endogenous IFI16 co-localizes with viral DNA during infection with 
KSHV, a gamma-herpesvirus, and IFI16 co-localizes with HSV-1 DNA when 
overexpressed in U2OS cells (Kerur et al., 2011; Li et al., 2012), consistent with the 
putative DNA binding activity of this protein (Unterholzner et al., 2010).  It is possible 
that viral DNA synthesis enhances the relocalization of IFI16 due to an increased 
availability of the viral PAMP;  therefore, we reinvestigated the localization of IFI16 
during infection with replication competent HSV-1.  HFF were infected with the 7134 or 
7134R viruses at an MOI of 10, fixed, and processed for immunofluorescence at 3 and 6 
hpi.  Viral replication compartments, sites of viral DNA synthesis (de Bruyn Kops and 
Knipe, 1988), were visualized with an antibody specific for the viral ICP8 single-stranded 
DNA binding protein.  In mock-infected HFF, IFI16 was nuclear and noticeably stained 
both the nucleoplasm and the nucleolus (Figure 4.5, panel a), as observed previously 
(Cristea et al., 2010; Orzalli et al., 2012).  In 7134R-infected cells we observed the 
accumulation of IFI16 in nuclear foci and the subsequent loss of IFI16 (Figure 4.5, 
panels i and f), consistent with our previous study describing the ICP0-dependent loss 
of IFI16 during HSV-1 infection (Orzalli et al., 2012).  This pattern of relocalization was 
not observed in 7134-infected cells.  Instead, we initially observed a decrease in 
nucleolar IFI16 at 3 hpi (Figure 4.5, panel d).  This loss did not appear to be due to 
degradation of the protein, as we did not observe a reduction in the steady state  
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Figure 4.5: IFI16 relocalizes to replication compartments during HSV-1 infection. 
Immunofluorescence of HSV-1 infected HFF.  HFF were infected with ICP0-null (7134) 
or rescued virus (7134R) at an MOI of 10 and fixed at 3 and 6 hpi.  Cells were 
simultaneously stained with mouse anti-IFI16 (abcam) and rabbit anti-ICP8 antibodies 
followed by Alexa Fluor 488 goat anti-mouse and Alexa Fluor 594 goat-anti rabbit 
secondary antibodies. 
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levels of IFI16 by western blot (Figure 4.2).  Instead, this initial redistribution is most 
likely a consequence of the viral disruption of cellular nucleoli (Calle et al., 2008; Greco 
et al., 2012).  At 6 hpi, we observed two distinct populations of 7134 infected cells: (I) 
cells with small replication compartments and diffuse IFI16 staining (Figure 4.5, panel l) 
and (II), cells with large replication compartments and notable IFI16 accumulation within 
those compartments (Figure 4.5, panel e).  These results indicate that in the absence of 
ICP0, IFI16 relocalizes to replication compartments as viral DNA synthesis progresses.  
 
Knockdown of IFI16 does not affect PML recruitment to viral genomes.  During the 
cellular response to HSV-1 infection, components of ND10 bodies accumulate at sites 
adjacent to viral DNA, which correlates with their involvement in the repression of viral 
replication (Everett et al., 2004b).  This accumulation is observed during infection with 
ICP0-null viruses, as wild-type virus infection overcomes ND10-mediated repression by 
targeting components of these domains for degradation in an ICP0-dependent manner 
(Boutell and Everett, 2012).  IFI16 has not been identified as an ND10 component, nor 
does it localize to nuclear foci that would be indicative of this domain in normal human 
foreskin fibroblasts (Figure 4.5) (Cristea et al., 2010; Orzalli et al., 2012).  However, 
given the involvement of IFI16 in the restriction of viral gene expression, we asked 
whether the protein is involved in the recruitment of ND10 components to viral 
genomes.  To answer this question, we utilized a technique previously developed for 
analyzing ND10 accumulation at sites of viral DNA entry into the nucleus.  This assay 
involves imaging cells along the edge of a viral plaque, where incoming viral genomes  
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Figure 4.6. ND10 component PML is recruited to sites associated with viral 
genomes in the absence of IFI16.  Immunofluorescence of non-targeting control or 
IFI16 siRNA transfected HFF infected with HSV-1.  HFF were treated with indicated 
siRNA for 72 hours prior to infection with an ICP0-null (7134) or rescued virus (7134R) 
at an MOI of 1 or 0.001, respectively.  Cells were fixed and simultaneously stained at 24 
hpi with mouse anti-ICP4 and rabbit anti-PML antibodies followed by Alexa Fluor 488 
goat anti-mouse and Alexa Fluor 594 goat-anti rabbit secondary antibodies. 
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accumulate asymmetrically in the cell nucleus (Everett and Murray, 2005; Silva et al., 
2008; Taylor, 2002).  HFF were treated with control siRNA or IFI16 siRNA to decrease 
IFI16 expression.  Cells were then infected with 7134 (MOI 1) or 7134R (MOI 0.001) 
and fixed at 24 hours post-infection.  Infection with 7134 at the higher MOI was 
necessary to observe plaque formation on HFF as ICP0-null viruses have up to a three-
log defect in plaque forming efficiency on human fibroblasts (Everett et al., 2008b).  
Incoming viral genomes were visualized with an antibody specific for the viral ICP4 
immediate-early protein, which has previously been shown to co-localize with viral DNA 
(Everett and Murray, 2005), and PML was used as a marker for ND10.  We observed no 
difference in the accumulation of PML at ICP4 foci in 7134-infected IFI16-knockdown 
cells compared to control cells, and PML was degraded in 7134R-infected cells 
irrespective of knockdown (Figure 4.6).  Furthermore, hDaxx was also recruited to 
genome complexes in the absence of IFI16 (results not shown), indicating this 
phenotype could be generalized to other ND10 components.  Together these results 
argued that the IFI16-mediated restriction of an ICP0-null mutant is not due to a 
disruption in ND10 activity. 
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Discussion 
 
 
During infection viruses are faced with a barrage of cellular intrinsic resistance 
and innate immune responses aimed to prevent their replication and spread.  
Herpesviruses, which are highly ubiquitous and can establish lifetime latent infections, 
robustly counteract these cellular responses through the expression of multiple 
immunomodulatory proteins.  This complexity has hindered the investigation of the host 
response to these viruses, as gene knockdown approaches (e.g., siRNA) rarely provide 
robust phenotypic information when infecting with wild-type-viruses that modulate the 
pathways investigated.   Therefore, to study the cellular responses to these large DNA 
viruses, one must use recombinant mutant viruses that do not express known 
immunomodulatory proteins.  In the case of HSV-1, the viral ICP0 immediate-early 
protein has been shown to inhibit both intrinsic resistance and innate immune 
responses to viral infection (Boutell and Everett, 2012; Roizman et al., 2013).  Previous 
studies using ICP0-null viruses have revealed that one major cellular response to DNA 
virus infection involves the silencing of incoming viral genomes, and while nuclear ND10 
have been implicated in partially mediating this host response, additional unknown 
factors have yet to be identified. 
In this study we established that the nuclear IFI16 DNA sensor is involved in the 
intrinsic cellular response to HSV-1 infection, as demonstrated by the increased 
expression and replication of an ICP0-null virus in the absence of IFI16.  Our 
investigation revealed that IFI16 did not affect the recruitment of ND10 components to 
viral genomes, indicating the intrinsic activity of IFI16 is independent of a previously 
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described DNA silencing response.  Interestingly, the complementation of the 7134 virus 
upon knockdown of IFI16 was similar to the remaining 10-fold inhibition observed in 
human fibroblasts when several ND10 components were simultaneously decreased by 
shRNA expression (Glass and Everett, 2012), suggesting that IFI16 may be the 
additional cellular repressor hypothesized in the aforementioned study.  Future studies 
investigating the simultaneous knockdown of ND10 components and IFI16 will be 
necessary to determine whether additional intrinsic resistance factors modulate ICP0-
null virus infection. 
The extent to which ICP0-null viruses are restricted for replication is cell type-
dependent.  Human fibroblasts are among the most restrictive cells for ICP0-null virus 
replication, while ICP0 is dispensable for growth in U2OS cells. The cellular 
mechanisms that impart these differences have not been identified.  Hancock et al 
(2006) reported that heterokaryon formation between U2OS cells and human fibroblasts 
imparted a dominant restrictive phenotype on U2OS cell nuclei, suggesting that U2OS 
cells lack a restrictive factor(s) that is functional in fibroblasts (Hancock et al., 2006).  
Others have examined the levels of known intrinsic resistance factors in U2OS cells 
(Lukashchuk and Everett, 2010), and it has been noted that these cells do not express 
ATRX, a component of ND10, however the addition of this protein failed to restrict HSV-
1 growth (McFarlane and Preston, 2011).  Surprisingly, U2OS cells expressed 
detectable IFI16 protein, which was inconsistent with the permissivity of these cells to 
ICP0-null virus infection.  The ability of HSV-1 to promote the degradation of exogenous, 
but not endogenous, IFI16 indicates this protein might be dysfunctional in tumor cell 
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lines and is consistent with reports that transformed cells lack a functional DNA sensing 
mechanism (Iwasaki, 2012).   However, the downstream factors involved in restricting 
viral gene expression appear to be functional, as exogenous IFI16 was able to restrict 
HSV-1 gene expression.  We therefore speculate that the permissivity of cells to ICP0-
null virus infection may, in part, rely on the functionality of IFI16 rather than whether the 
protein is expressed in a given cell-type.  In addition, these results provide a basis for 
the further investigation of IFI16 activity in the absence of other restrictive phenotypes.    
The inhibitory response mediated by IFI16 was not limited to DNA introduced by 
viral infection as we also observed an increase in the expression of transfected DNA in 
the absence of IFI16.  It is well documented that exogenous plasmid DNA can be 
silenced upon transfection, and that this has been a significant drawback to the use of 
non-viral vectors in gene therapy (Al-Dosari and Gao, 2009; Jackson et al., 2006).  
Interestingly, cell lines that do not express IFI16 (293T cells) (Kwak et al., 2003) or have 
mutations that prevent the nuclear localization of IFI16 (PC3) (Xin et al., 2003), 
demonstrate enhanced mRNA expression of transfected DNA when compared to other 
cell lines (Karyala et al., 2010).  While Karyala et al (2010) do not discuss the potential 
activity of IFI16 in their system, our results indicate IFI16 might play a role in inhibiting 
foreign DNA expression in non-transformed cells and warrants further investigation. 
One critical question raised by this study involves the potential cellular 
components that act in concert with IFI16 to mediate its intrinsic activity.  The ER-
associated STING scaffolding protein has been shown to co-immunoprecipitate with 
IFI16 and is downstream of this nuclear protein in the activation of IRF-3 (Orzalli et al., 
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2012; Unterholzner et al., 2010), but we found in our knockdown studies that STING is 
not involved in the intrinsic antiviral response to HSV-1 infection.  As IFI16 is nuclear in 
HFF and inhibits viral gene expression in the nucleus, additional nuclear proteins may 
be involved in the observed phenotype.  IFI16 is a member of the PHYIN (Pyrin and 
HIN) family of proteins, which includes AIM2, MNDA, and IFIX.  Typically these proteins 
activate signaling cascades through homotypic interactions with other pyrin-containing 
proteins.  For instance, upon binding cytosolic DNA, AIM2 interacts with ASC in a pyrin-
dependent manner to initiate inflammasome signaling (Hornung et al., 2009).  
Interestingly, ASC has also been reported to co-localize with IFI16 in the nucleus during 
KSHV infection of endothelial cells (Kerur et al., 2011) and we have observed an 
intranuclear relocalization of IFI16 reminiscent of inflammasomes during ICP0-null virus 
infection.  However, we have not determined whether this relocalization is necessary for 
IFI16 activity nor whether ASC co-localizes with IFI16 in human fibroblasts.  
IFI16 has been shown to associate with other cellular proteins that lack pyrin 
domains, including BRAC1.  Interestingly, BRAC1 has previously been shown to 
accumulate in HSV-1 replication compartments (Taylor and Knipe, 2004);  however, this 
accumulation was observed during wild-type HSV-1 infection and we have observed no 
difference in BRCA1 recruitment in the presence or absence of ICP0 (results not 
shown), suggesting this protein is not involved in the silencing of viral DNA.  The 
identification of additional IFI16-interacting proteins and their involvement in both the 
intrinsic and innate functions of IFI16 will further our understanding of IFI16 activity and 
is a high priority for future studies. 
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The mechanism(s) by which IFI16 decreases the expression of exogenously 
introduced DNA is unclear.  In a study using HCMV, it was proposed that IFI16 
sequesters the Sp1 transcription factor making it unavailable to promote viral gene 
expression (Gariano et al., 2012).  However, several HCMV immediate-early promoters 
containing Sp1-binding sites were not enhanced by IFI16 knockdown and an additional 
study implicated IFI16 as positive regulator of CMV replication (Cristea et al., 2010), 
complicating this interpretation.  In addition, we observed an IFI16-dependent 
repressive effect on a plasmid containing the EF1 alpha promoter, which does not 
contain an Sp1 binding site.  Further insight into the activity of IFI16 may be garnered by 
work investigating HSV-1 ICP0ʼs role in enhancing virus replication.   ICP0 is a known 
transactivator of viral genes and its expression promotes both histone removal and 
acetylation of viral DNA during lytic infection (Cliffe and Knipe, 2008).  Furthermore, 
Frenzcy et al (2009) reported that expression of ICP0 from a recombinant HSV-1 virus 
was sufficient to reduce the H3me3K9 heterochromatic mark on viral DNA when 
compared to a virus expressing no viral gene products (Ferenczy and DeLuca, 2009). 
Together, these data suggest ICP0 promotes a more “open” chromatin state, one that is 
associated with transcriptional activity.  Based on these reports and our observations of 
both IFI16 restricting viral gene expression and ICP0 targeting IFI16 for degradation to 
promote virus replication, we hypothesize that IFI16 is involved in recruiting chromatin 
remodeling complexes and/or histones to foreign DNA.   
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In conclusion, the results presented in this study indicate that in addition to its 
involvement as an innate pattern recognition receptor, IFI16 plays a broader role in the 
sensing and silencing of foreign DNA as a mediator of intrinsic cellular resistance.  
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Chapter Five: Dissertation Perspective 
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Summary of Results. 
The work presented in this dissertation was directed at understanding how HSV-
1 is sensed by the cell upon infection, and how the viral ICP0 protein counteracts this 
response.  Prior to this study, the induction of a type I interferon response to HSV-1 
infection was thought to occur through cytosolic sensing of viral DNA.  However, in light 
of the replication cycle of HSV-1, we hypothesized that viral DNA may also be sensed in 
the nucleus during infection.  We tested this hypothesis by establishing an infection 
model in normal human foreskin fibroblasts where we could examine the requirements 
for IRF-3 activation in response to replication-defective HSV-1.  The results from 
experiments using this model strongly argued that the release of viral DNA into the 
nucleus was required to activate a type I interferon response to infection.  Furthermore, 
we identified the nuclear IFI16 DNA sensor as an important component of this response.  
 The identification of both the site of sensing and the components involved in this 
process allowed us to identify steps in the signaling cascade inhibited by the viral ICP0 
protein.  In chapter three we demonstrated that ICP0 has both an early and late effect 
on IFI16-dependent signaling.  We observed that early during infection ICP0 promotes 
the intranuclear relocalization of IRF-3 and that this is associated with the inability of 
IRF-3 to bind to cellular promoters.  Based on these results we hypothesize that ICP0 
inhibits IRF-3 by sequestering the protein away from cellular promoters, although as 
discussed in chapter two, the mechanism of this sequestration is unknown. The 
inhibition of IRF-3 signaling by ICP0 later during infection appears to be due to the 
ICP0-dependent degradation of IFI16.  Loss of IFI16 during infection inhibits activation 
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of downstream signaling and prevents accumulation of IRF-3 in the nucleus.  Together 
these results argue for a dual mechanism of ICP0-mediated inhibition.  
In chapter four of this dissertation, we further characterized the activity of IFI16 
during HSV-1 infection and provided evidence of an IFI16-dependent intrinsic repressive 
response to foreign DNA.  We demonstrated that IFI16 restricts the replication of an 
ICP0-null virus independently of STING, indicating that this response does not involve 
the antiviral activity of type I interferons.  While knockdown of IFI16 in HFF enhanced 
ICP0-null virus immediate-early gene expression, the converse was true when IFI16 
was overexpressed in the complementing U2OS cell line, indicating that IFI16-
dependent repression occurs early during infection.  The repressive activity of IFI16 was 
not limited to viral DNA as the expression of transfected DNA was also inhibited by 
IFI16, suggesting that IFI16 acts broadly to repress foreign DNA. 
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Discussion 
Nuclear vs cytosolic innate sensing of HSV-1 DNA. The lifecycle of HSV-1 lends 
itself to being sensed by a variety of cell types during infection.  While lytic replication 
occurs within the mucosal epithelium, innate immune cells that reside in the lamina 
propria continually sample this site for foreign pathogens.  Current data suggests that 
the cellular components and compartments involved in sensing HSV-1 are cell type-
dependent.  For instance, dendritic cells, which are important interferon producers, 
sense HSV-1 in endosomal compartments in a TLR9-dependent manner (Lund et al., 
2003).  Cytosolic sensing of viral DNA has also been implicated in HSV-1 infection with 
the discovery of several putative cytosolic DNA sensors.  
In this dissertation we present evidence of the existence of a nuclear sensing 
mechanism important for the activation of IRF-3 signaling in response to HSV-1.  This 
response required the release of viral DNA into the nucleus and was, at least in part, 
dependent on the expression of the IFI16 DNA sensor.  While exclusively nuclear in the 
normal human fibroblasts used in this study, IFI16 can be found at low levels in the 
cytosol of certain cell types, particularly those of myeloid lineage.  IFI16-dependent 
cytosolic sensing of HSV-1 has been investigated in bone marrow-derived macrophage 
and PMA-differentiated THP-1 cells, both of which are highly restrictive for viral 
replication.  While viral DNA is normally protected from cytosolic sensors by the viral 
capsid, Horen et al (2013) recently reported that in macrophages, viral DNA is made 
available to cytosolic sensors via proteasomal degradation of incoming viral capsids 
(Horan et al., 2013).  This mechanism does not appear to be involved in sensing HSV-1 
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in human fibroblasts, as we did not observe an MG132-dependent effect on the 
activation of IRF-3 signaling.  Furthermore, this response appears to be specific to 
immune cells as expression of a cytosolic restricted IFI16 in HEK293 cells was not 
sufficient to induce IFN" expression in response to HSV-1(Li et al., 2012).  These 
results indicate that non-immune cells potentially lack the components necessary to 
target viral capsids for degradation and the release of DNA into the cytosol. 
The cell type specificity for cytosolic or nuclear sensing appears to correlate with 
the permissivity of these cells to HSV-1 infection.  Myeloid cells are highly restrictive for 
viral gene expression and replication, while fibroblasts support robust productive 
replication.  It is unclear why myeloid cells are restrictive for HSV-1 infection;  however, 
cytosolic degradation of incoming capsids may inhibit efficient viral DNA accumulation in 
the nucleus thus preventing viral gene expression and replication.  As such, the immune 
evasion strategies employed by HSV-1 that rely on viral gene expression may not be 
active in myeloid cells.  This is consistent with reports that a type I interferon response 
is important for the control of HSV-1 infection in vivo (Conrady et al., 2011; Luker et al., 
2003), even though permissive cells (e.g., epithelial cells and fibroblasts) robustly 
counteract the innate immune response.  We therefore propose that the localization of 
IFI16-dependent sensing depends on both the compartment where IFI16 is expressed 
and the permissivity of these cells for viral replication.  If this hypothesis proves correct, 
one would expect that the expression of the proteins required for promoting viral capsid 
ubiquitination and degradation would make cytosolic sensing of HSV-1 possible in 
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permissive cells.  However, it is currently unclear how viral capsids are targeted for 
degradation in macrophages. 
There appears to be at least one additional difference between IFI16-dependent 
cytosolic and nuclear sensing of HSV-1 DNA.  Both the cytosolic and nuclear DNA 
sensing mechanisms require STING to mediate the activation of IRF-3 in response to 
HSV-1 infection.  In addition, STING has also been shown to couple the cytosolic DNA 
sensing response to NF-#B activation (Ishikawa and Barber, 2008), and knockdown of 
IFI16 inhibited NF-#B signaling in HSV-1 infected macrophages (Unterholzner et al., 
2010).  However, in chapter two we observed that expression of an NF-#B-dependent 
gene was induced equally in both d109- and d106-infected HFF, suggesting this 
response was IFI16-independent.  While it is still unclear how STING activates NF-#B 
signaling in response to DNA, our results indicate that this response is either not active 
in human fibroblasts, or alternatively, cytosolic and nuclear sensing of DNA differentially 
induce NF-#B signaling.  This may indicate that cytosolic and nuclear IFI16 use different 
adaptor proteins to potentiate downstream signaling events. 
 
Possible mechanisms for the differentiation of endogenous and foreign DNA in 
the nucleus.  One of the most intriguing questions to have arisen from this study is how 
the cell differentiates between self and non-self DNA in the nucleus.  One potential 
mechanism is informed by the recently described crystal structure of the IFI16 HINb 
domain in complex with DNA (Jin et al., 2012).  Jin et al reported that IFI16 interacts 
with DNA in a non-sequence specific manner through electrostatic interactions with the 
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sugar-phosphate backbone.  In addition, the DNA itself appears to act as a scaffold for 
IFI16 oligomerization.  Cellular DNA is tightly associated with nucleosomes, which could 
preclude the DNA from acting as a signaling platform for IFI16, thus limiting the 
response to self-DNA.  In contrast, while HSV DNA is known to be chromatinized rapidly 
upon entry into the nucleus (Cliffe and Knipe, 2008; Oh and Fraser, 2008), histone 
association with HSV DNA is less densely packed (Cliffe and Knipe, 2008) and looser 
(Lacasse and Schang, 2010) than cellular chromatin, and this reduced histone load may 
provide IFI16 access to viral DNA.  Alternatively, HSV may be sensed prior to the 
chromatinization of its genome.  While we have not directly shown that IFI16 binds to 
HSV DNA in our system, the former hypothesis is supported by our observation that 
IFI16 accumulates in replication compartments where newly synthesized DNA is known 
to be histone free (Maul et al., 1996; Oh and Fraser, 2008; Simpson-Holley et al., 2004). 
This hypothesis can be further examined by directly testing whether IFI16 can 
bind DNA in the presence or absence of chromatin.  As stated above, the IFI16 HIN (a 
and b) domains have previously been shown to bind DNA in vitro.  Therefore, in vitro 
chromatinized DNA can be tested for IFI16 binding activity in a similar manner.  If this 
hypothesis proves correct, we would expect the IFI16 HIN domains to bind in vitro 
chromatinized DNA less efficiently than naked DNA.  The functionality of this hypothesis 
can also be tested in cell culture by examining the cellular innate immune response to 
virus infection in cells that do not express HIRA or asf1, the histone chaperone proteins 
important for the early chromatinization of HSV DNA (Oh et al., 2012; Placek et al., 
2009).  
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An alternative, although not mutually exclusive, argument could be made for viral 
DNA being the second signal in a two-step mechanism of host cell sensing.  Using 
HSV-1 VLPs that lack DNA, Holm et al (2012) recently reported that membrane 
perturbation induced a low level of IFN! expression and enhanced the cellular response 
to subsequent stimuli.  The authors hypothesized that membrane fusion could act as a 
“danger” signal to prime the cell for additional viral stimuli.  The exact mechanism that 
links viral fusion to the production of type I interferons is unclear, although it appears to 
involve the activation of PI(3)K (Holm et al., 2012).  Furthermore, others have proposed 
that PI(3)K may play a role in the phosphorylation of IRF-3 (Sarkar et al., 2004), 
although a potential mechanism was not explored in the referenced study.  Based on 
these reports, it is possible that membrane perturbation primes IRF-3 in a way that 
enhances IFI16 signaling in response to DNA.  However, it is currently unclear whether 
this priming response is necessary for the DNA-dependent response to HSV-1 infection. 
 
Mechanisms of IFI16-dependent innate and intrinsic signaling.  The results 
presented in chapters three and four of this dissertation argue that IFI16 is capable of 
acting as both an effector of the innate response and as an intrinsic resistance factor to 
foreign DNA.  These IFI16-dependent responses appear to be separable; as the 
activation of type I interferon in human fibroblasts requires STING, while the intrinsic 
response acts independently of this adaptor molecule.  However, it is currently unclear 
how IFI16 mediates either of these responses.  
Our proposed model of innate nuclear HSV-1 DNA sensing requires the 
transduction of the sensing event to the cytoplasm to activate IRF-3 signaling.  This is 
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supported by multiple observations, including the nuclear localization of IFI16, the 
involvement of cytoplasmic STING, and that blocking nuclear export results in 
decreased phosphorylation of TBK1 during infection.  It has been proposed that a 
general feature of innate immune signaling is the ability to dissociate the site of PAMP 
recognition from that of signal transduction (Kagan, 2012).  In many cases this appears 
to involve the transport of the sensor itself following ligand binding.  While the 
intracellular localization of IFI16 can change through the acetylation of its nuclear 
localization signal (Li et al., 2012), we did not observe a measureable relocalization of 
IFI16 to the cytoplasm in d109-infected cells, suggesting that an additional protein may 
bridge these two compartments.  However, we cannot rule out that a small portion of 
IFI16 translocates to the cytoplasm to initiate signal transduction.  
While nuclear innate sensing of viral DNA is a novel finding of this study, the 
existence of an intrinsic repressive response to foreign nuclear DNA has been known 
for some time.  The mechanisms underlying this response have remained unclear, 
although the repression has been observed for both viral and plasmid DNA.  In this 
study we demonstrate that IFI16 is involved in the cellular silencing of exogenous DNA. 
However, we do not identify the mechanism by which IFI16 restricts gene expression. 
IFI16 was first implicated as a repressor of transcription over a decade ago when 
IFI16 fused to a GAL4 DNA binding domain was shown to inhibit the expression of a 
GAL4 reporter construct (Johnstone et al., 1998).   In a recent study using HCMV, it was 
proposed that IFI16 sequesters the Sp1 transcription factor making it unavailable to 
promote viral gene expression (Gariano et al., 2012).  The co-immunoprecipitation of 
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IFI16 with Sp1 required the HIN-B domain of IFI16.  However, this domain was 
dispensable for the repression observed by Johnstone et al (1998).  In addition, in 
chapter four we observed an IFI16-dependent repression of the EF1" promoter, which 
does not contain an Sp1 binding site.  Therefore, sequestration of Sp1 cannot account 
for several reported IFI16 repressive activities.  
 It has been hypothesized that changes in chromatin structure may play a role in 
the silencing of exogenous DNA.  This is supported by observations that transcriptional 
repression of viral and plasmid DNA occurs concomitantly with an increase in histone 
associated-heterochromatic marks (Knipe and Cliffe, 2008; Riu et al., 2007).  During 
HSV-1 infection the ICP0 protein counteracts this repression and promotes viral gene 
expression (Knipe and Cliffe, 2008).  This appears to be partly due to the disruption of 
ND10 bodies (Boutell and Everett, 2012), which are sites of intrinsic antiviral resistance. 
However, results from our study indicate that ICP0-dependent degradation of IFI16 also 
plays a role in the derepression of viral DNA.  Based on these observations, we 
hypothesize that IFI16 may silence viral and plasmid DNA by promoting their 
association with heterochromatin. 
 The factors that mediate both the innate and intrinsic effects of IFI16 have not 
been defined.  The use of proteomics to identify potential IFI16 interactors may provide 
additional information on the activities of IFI16 observed in this study. Proteins identified 
by this approach can then be tested for their activity in both IRF-3 signaling and the 
repression of foreign DNA. 
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Potential for additional innate nuclear sensing mechanisms.  As stated in the 
introduction, several putative DNA sensors have been identified as activators of type I 
interferon in response to viral DNA although none have been universally accepted by 
the field (Burdette and Vance, 2013).  This is mainly due to the modest response seen 
when individual putative DNA sensors are silenced by siRNA.  However, it has been 
hypothesized that this effect may be due to functional redundancy within the DNA 
sensing pathway.  This has been observed recently in THP-1 cells where cytosolic 
sensing of HSV-1 DNA was shown to be dependent on both IFI16 or ddx41 (Horan et 
al., 2013).  
In this study, we observed that knockdown of STING, although less efficient than 
IFI16 knockdown, resulted in a greater inhibition in the expression of IFN" in response 
to HSV-1 infection.  This could indicate that an additional nuclear sensing mechanism 
exists in these cells.  Currently the AIM2-like family of receptors (ALR), of which IFI16 is 
a member, is composed of four human and thirteen mouse proteins.  Expression of the 
individual ALR proteins in 293T cells expressing STING induced varying type I 
interferon responses (Brunette et al., 2012), indicating some functional redundancy 
within the family.  While human AIM2 is cytoplasmic, and thus unlikely to be involved in 
the nuclear sensing of HSV-1, both IFIX and MNDA are localized to the nucleus, making 
them potential nuclear PRR candidates.  Examining whether individual or simultaneous 
knockdown of the human ALR family members affects the IRF-3 response to HSV-1 
infection would test this hypothesis.  
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Recently, Wu et al (2013) made the intriguing observation that both transfected 
DNA and HSV-1 infection induces the production of cyclic GMP-AMP (cGAMP), which 
binds to STING and promotes IRF-3 signaling (Wu et al., 2012).  Knockdown of the 
cGAMP synthase responsible for the production of this second messenger resulted in a 
decreased antiviral response to a 'ICP34.5 HSV-1 virus in both mouse L929 cells and 
human THP1 cells (Sun et al., 2012).  While expression of both STING and cGAMP 
synthase in HEK293T cells was sufficient to activate IRF-3 in response to transfected 
DNA, this sufficiency was not examined during HSV-1 infection.  It is possible that IFI16 
and cGAMP synthase work in concert to activate IRF-3 or are involved in distinct 
signaling pathways that both utilize STING as an adaptor molecule.  The HSV-1 virus 
used by Wu, Sun, and colleagues (2012) expresses ICP0, and would thus potently 
inhibit the IFI16/p204-dependent response to viral infection;  therefore, it is likely that 
IFI16 and cGAMP synthase sensing is separable.  Furthermore, others have 
demonstrated that STING recognition of cyclic dinucleotides and the production of IFN! 
in the response to transfected viral DNA (VV70mer) can be decoupled in bone marrow 
derived macrophage (Burdette et al., 2011), suggesting that multiple mechanisms of 
sensing exist within a single cell type.   
 
How does ICP0 promote the degradation of IFI16?  ICP0-null HSV-1 mutants are 
subject to an enhanced type I interferon response and repression through intrinsic 
resistance mechanisms.  Prior to this study, ICP0 was known to counteract both 
responses;  however, the mechanism of action had not been thoroughly defined.  In this 
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dissertation we demonstrate that ICP0 overcomes these two DNA-dependent responses 
by promoting the degradation of nuclear IFI16.  
Several questions remain unanswered with regards to this aspect of our study, 
including how ICP0 targets IFI16 for degradation.  As stated in the Introduction, ICP0 
promotes the degradation of cellular proteins through diverse means, including direct 
protein interactions, phosphospecific interactions, and SUMO-dependent and –
independent mechanisms.  Alternatively, it has been proposed that some ICP0-
dependent degradation events may be downstream effects of ICP0 targeting another 
cellular protein.  We believe that it is unlikely that the loss of IFI16 observed in this study 
is a secondary consequence of another degradation event due to the observed 
relocalization of IFI16 to ICP0 foci during infection.  This phenotype is similar to that 
seen with several direct ICP0 targets, including the C-terminal domain of PML.I and 
RNF8 (Cuchet-Lourenco et al., 2012; Lilley et al., 2010).  However, formal testing of 
whether IFI16 is a direct or indirect interactor of ICP0 will help strengthen this argument.  
 Currently, IFI16 has not been reported to possesses any of the substrate motifs 
that ICP0 is known to interact with when targeting proteins for degradation.  In chapter 
three we attempted to elucidate the ICP0 domains necessary for this event by testing a 
panel of ICP0 mutants for their ability to degrade IFI16.  Surprisingly, the N-terminus of 
ICP0 (amino acid residues 1-105) was important for this activity.  Interestingly, over a 
decade ago, a potential role for the N-terminal domain of ICP0 in the transactivation of 
immediate-early gene expression was reported (Lium et al., 1998).  Deletion of the first 
105 amino acids of ICP0 decreased immediate-early gene expression and replication of 
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the mutant virus by approximately 10-fold.  The FHA binding activity of ICP0 has been 
mapped to this region;  however, we do not believe that this activity of ICP0 is 
necessary to degrade IFI16 because a mutant lacking this binding site showed very little 
growth defect in HFF (Chaurushiya et al., 2012).  Additional mutational analysis of this 
region will potentially reveal a novel mechanism of ICP0 substrate specificity.   
  
Implications for replication-defective vaccine design.  Replication-defective HSV 
vaccines are currently being explored as potential vaccine vector candidates.  The HSV-
1 d106 recombinant virus used in this study has shown good immunogenicity in a 
rhesus macaque model of SIV infection (Kaur et al., 2007).  However, the protective 
capacity of this vaccine vector to SIV challenge was limited for unknown reasons.  While 
the correlates of protection for vaccine design are not well understood, eliciting a 
stronger immune response may increase the efficacy of this vaccine vector.  
One potential approach to increasing the efficacy of virus-based vectors is to 
delete (or modify) immunomodulatory genes that are encoded by the vector.  It is clear 
from this study and work by others (Eidson et al., 2002) that expression of ICP0 from 
the d106 virus blunts the cellular innate immune response to infection.  However, 
expression of ICP0 also prevents silencing of viral chromatin and subsequently 
enhances the expression of the transgene to which an immune response is being 
elicited.  Therefore, while deletion of ICP0 would enhance the innate immune response 
to the d106 virus, it would also likely decrease transgene-specific immunogenicity of this 
vector.  
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Prior to this study it was unclear whether the transactivating capability and 
immunomodulatory activity of ICP0 could be decoupled.  While we demonstrated that 
both of these ICP0-dependent responses rely, in part, on the degradation of IFI16, we 
also observed that ICP0 inhibits the innate immune response by sequestering IRF-3. 
This response was independent of the RING-finger activity of ICP0, which is required for 
the proteinʼs transactivating potential.  By understanding how ICP0 sequesters IRF-3 in 
a RING finger-independent manner it may be possible to enhance the innate immune 
response to the d106 vector without decreasing transgene expression. 
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